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ABSTRACT
The extracellular microenvironment contributes significantly to a cell’s function
and behavior. For instance, cell-cell interactions, cell-substrate interactions, and physical
forces are all factors of the extracellular environment that can alter cellular behavior.
Cells can receive these signals and forces through various membrane channels and
receptors that transmit the signals from the extracellular to the intracellular space.
Canonical Notch signaling is induced by ligand interactions with neighboring cells, but
recent evidence has revealed that Notch signaling can occur through a variety of
extracellular stimuli including hyperglycemia, hypoxia, multiple growth factors, fluid
shear stress, and extracellular matrix (ECM) composition. Although Notch activation
through ligand interactions with adjacent cells have been well established, non-canonical
Notch signaling through the microenvironment is poorly understood. Previous evidence
suggests a novel activation of Notch signaling through an integrin pathway, proposing
Notch as a microenvironmental sensor. Integrins are cell membrane receptors that are
mainly recognized for cell-ECM attachment and induction of cellular signaling cascades
but have also been shown to respond and transmit signaling through fluid shear stress and
ECM stiffness. Since integrins have been shown to regulate Notch signaling and both
exhibit a response to fluid shear stress, we hypothesized that Notch signaling responds to
fluid shear stress through integrin activation. To test this, we compared Notch activation
following exposure to fluid shear stress and Notch activation following shear stress after
inhibiting integrin function. Our data confirms that Notch activation is significantly
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upregulated from fluid shear stress compared to a static control and inhibiting integrin
function attenuates this response, suggesting integrins are required for Notch’s
upregulation from shear stress. Because integrins also respond and transmit signals from
varying ECM stiffness and Notch has been shown to be upregulated during conditions of
fibrosis, we hypothesized that Notch signaling will be regulated by varying degrees of
ECM stiffness through integrin activation. To investigate this hypothesis, we cultured
cells on hydrogels with multiple levels of stiffness and measured Notch signaling. Our
results indicate that like shear stress, Notch signaling is influenced by ECM stiffness.
Collectively our results indicate that Notch signaling is regulated through
microenvironmental forces like fluid shear stress and ECM stiffness and is regulated
through integrins. This furthers our understanding of the variations of Notch signaling in
response to microenvironmental stimuli and the mechanisms involved. Notch has been
implicated in a variety of diseases and our results improve our knowledge of Notch
signaling in pathological conditions of the microenvironment including abnormal shear
stress (e.g. atherosclerosis) and tissue stiffness (e.g. fibrosis).
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CHAPTER ONE: INTRODUCTION

Cellular Signaling
The biological cell is the fundamental unit that make up living organisms. Each
cell contains the individual’s genetic information that will induce certain phenotypes to
regulate functions like cellular differentiation and homeostasis. One of the ways that cells
fulfill these necessary tasks is by communicating with the genome from extracellular
cues. When receptors receive these microenvironmental triggers, a biochemical cascade
event will ensue transferring information via small molecules (e.g. phosphorylation,
ubiquitination) via specific transporters (e.g. kinases, ubiquitin ligases) between signaling
intermediates. Kinases can phosphorylate either tyrosine residues or serine/threonine
residues on proteins which will alter their behavior and phosphatases can counteract this
event by removing the phosphate group. Eventually this cascading phenomena will
influence genetic expression by molecules either binding to the DNA itself (e.g.
transcription factors) or by binding to existing proteins on the DNA (co-transcription
factors). This will cause genes to either upregulate or downregulate the expression of
mRNA leading to the construction or degradation of functional proteins. Ultimately,
without cellular signaling, cells would have no information as to guide them to
differentiation, apoptosis, migration, mitosis, and many other cellular fates.
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The Cellular Microenvironment
Cells exist in a large variety of local microenvironments and the scope of these
environments largely depend on the type of cell and its physiological location in the
body. Each cell’s specific location offers differing micro environmental stimuli like
neighboring cell interactions (e.g. cell-cell, signaling molecules), extracellular matrix
composition (e.g. stiffness, stretching), osmolality, temperature, acidity, and fluid shear
stress. Cells can also manipulate their own microenvironment. Fibroblasts secrete
extracellular matrix (ECM) proteins changing the surrounding matrix composition and
stiffness. Arguably, the most notable example of cells manipulating their surroundings is
the tumor microenvironment. Tumor cells display an autocrine-like behavior with the
microenvironment, creating their own physical surroundings like pH change and hypoxia
to promote the degradation of the extracellular matrix to increase invasiveness (Gillies &
Gatenby, 2007). They have also been shown to manipulate production of growth factors
(e.g. VEGF) to promote angiogenesis from nearby vessels to supply the starving tumors
with the appropriate nutrients and oxygen (Juczewska & Chyczewski, 1997). Many
pathologies are related to micro environmental changes like abnormal ECM stiffness, a
common characteristic of fibrosis, and abnormal shear stress, which is linked to
atherosclerosis. Because the microenvironment is involved in a large portion of ailments,
it has become a focal point for numerous research studies. Understanding how cells
respond to their microenvironment and the molecular mechanisms involved is crucial for
developing strategies to counteract related pathologies.
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Notch Receptors
Overview
Notch is a heterodimeric, transmembrane ligand receptor that when activated
becomes a co-transcription factor and is important in most tissues for functions like
proliferation, development, and migration. The discovery of Notch occurred more than
100 years ago (1914) and was linked to a loss of function “notch” phenotype in the wings
of Drosophila melanogaster (Metz & Bridges, 1917). In mammals, four homologs of
Notch (Notch 1-4) and five canonical ligands (Jagged1, and 2 and Delta-like 1,3 and 4),
which are exhibited on adjacent cells, have been recognized. The Notch receptor can be
divided into three domains: the extracellular, transmembrane and intracellular domain.
The extracellular domain (NECD) is made up of 36 epidermal growth factor (EGF)-like
repeats responsible for ligation (Wharton, Johansen, Xu, & Artavanis-Tsakonas, 1985).
The transmembrane portion consists of three Lin-12-Notch (LN) repeats mediating the
extracellular-intracellular interactions (Fiuza & Arias, 2007), and the intracellular domain
(NICD) which has an RBP-J associated molecule (RAM) followed by seven ankyrin
repeats connected to a proline, glutamine, serine, and threonine-rich (PEST) domain and
a transactivation domain (TAD) responsible for transcriptional activity (Fiuza & Arias,
2007) (figure 1.1). From initial expression to transcriptional regulation, Notch
experiences a total of three cleavage events. The first cleavage (S1) of Notch is carried
out by the cleaving enzyme Furin and occurs during transportation through the Golgi
complex morphing the full length protein into two non-covalently attached heterodimeric
portions (Logeat et al., 1998). Notch is then O-linked glycosylated for the proper folding
conformation to occur before it is secreted to the cell membrane. Once the final
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membrane destination is reached, Notch activation may occur via ligand binding or
independently of ligand binding. The second cleavage (S2) is carried out by the
metalloproteinase ADAM, completing the extracellular domain separation. This cleavage
may happen through a ligand-dependent or independent manner. Recent work has
revealed that ADAM10 cleavage activation might happen through ligand-dependent
activation whereas ADAM17 may be responsible for ligand-independent activation
(Bozkulak & Weinmaster, 2009; Christian, 2012). During Notch ligand-dependent
activation in vertebrates, membrane proteins on adjacent cells (Jagged, Delta-like)
activate Notch by attaching to the extracellular domain. The adjacent cells then
endocytose the ligand and NECD which induces ADAM to cleave the extracellular
domain. Finally, a subsequent third cleavage (S3) takes place in which gamma secretase
excises the intracellular domain at the plasma membrane (Sorensen & Conner, 2010;
Struhl & Adachi, 2000) where the NICD will then travel to the nucleus to take part in
transcriptional regulation.
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Figure 1.1: Domains of the Notch receptor. The extracellular domain (NECD) of
Notch contains 36 epidermal growth factor (EGF)-like repeats, followed by a
transmembrane portion containing Lin-12-Notch repeats. The intracellular domain
(NICD) consists of RAM, Ankyrin repeats, transactivation domain (TAD) and
proline, glutamine, serine, and threonine (PEST)-rich domains and is responsible
for transcriptional control.
Downstream Notch Signaling
For transcriptional activity, the NICD doesn’t actually bind to the DNA, but rather
dimerizes with recombining binding protein suppressor of hairless (RBP-J or CSL) where
it acts as a co-transcription factor along with other factors like p300 and MAML. The
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most widely recognized downstream targets of Notch signaling are the Hair and
Enhancer of Split Family (Hes, Hey) genes. In Drosophila melanogaster, these genes
regulate developmental processes like segmentation through expression of basic Helixloop-helix (bHLH) proteins. In rodent genomes, seven Hes and three Hey genes have
been recognized, whereas only Hes1, 5, and 7 have been shown to be activated by Notch
while all three of the Hey genes (Hey1, 2, and L) show induction by Notch signaling as
reviewed by Fischer and Gessler (Fischer & Gessler, 2007). Hes genes are involved in
sensory organ, nervous system, pancreas and endocrine cell development, where the Hey
genes tend to be involved in the cardiovascular system (Fischer & Gessler, 2003, 2007).
Canonical vs Non-Canonical Activation
The most widely understood mechanism for Notch activation is through ligand
binding from adjacent cells. As previously mentioned, Delta and Jagged are membrane
bound ligands that bind Notch on adjacent cells causing endocytosis and inducing the
Notch cleavage events leading to downstream genetic signaling. Conversely, during a
“cis-ligand” interaction, Notch interacts with Delta and Jagged on the same cell, which
inhibits Notch activation (Palmer, Jia, & Deng, 2014). Recently, evidence has surfaced
that Notch signaling can be induced through ligand-independent methods rather than by
conventional means. One method proposed that Notch signaling can happen by a
disruption in genes, causing abnormal endosomal sorting and ubiquitination. When Notch
is ready for degradation, Notch is polyubiquinated and is sorted into intraluminal vesicles
for transport to the lysosome. The NICD can be accidently removed from the NECD
when ensnared on the outer endosome membrane, mimicking activation (Palmer & Deng,
2015). Other methods have also been proposed to induce Notch signaling independent of
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ligand activity through micro environmental stimuli. In Drosophila, it was shown that the
homolog to mammalian hypoxia inducible factor- (HIF-) activated Notch signaling
independent of ligand interactions (Mukherjee, Kim, Mandal, & Banerjee, 2011),
suggesting hypoxic environments lead to the signaling event. Experimentally, Notch can
be activated independent of ligand binding by calcium chelation. Notch LN repeats are
connected to the NECD by calcium bridges, and when a calcium chelator (e.g. EDTA) is
applied, the NECD dissociates and induces the cleavage activation events. Knowing that
Notch signaling can be induced in a ligand-independent manner has opened many doors
into the investigation of Notch signaling by other non-canonical means.
Notch Signaling and Disease
Since Notch signaling is involved in countless cellular functions, it’s not
surprising that Notch signaling is also associated with many diseases. Hereditary
pleiotropic disease, metabolic bone disease, cardiovascular and cerebrovascular disease,
and most notably cancers are just a few of the associated ailments involving Notch
signaling (Louvi & Artavanis-Tsakonas, 2012). Notch was first recognized as an
oncogene in 1991 when chromosomal rearrangements were discovered in human T-cell
acute lymphoblastic leukemia (T-ALL), an aggressive hematologic tumor, effecting the
human Notch1 gene by causing abnormal activation of Notch signaling (Chan et al.,
2013; Louvi & Artavanis-Tsakonas, 2012; Tosello & Ferrando, 2013). Notch has also
been shown to be involved in breast cancer (Gallahan & Callahan, 1997), multiple
myeloma (plasma cell cancer) (Colombo et al., 2015), and adenocarcinomas (Yuan et al.,
2015) among others. Notch also aids tumor progression by inducing pro-angiogenic
effects and is involved in the epithelial to mesenchymal transition process contributing to
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tumor metastasis. Due to the numerous activities that Notch regulates, therapeutic
targeting of Notch is extremely difficult. Further understanding of Notch and its relation
to these pathologies will aid researchers in potentially circumventing these possible
pitfalls.
Integrins
Overview
Integrins are transmembrane receptors that heterodimerize between two subunits,
alpha and beta, and are mainly known for attaching the cell to a matrix substrate creating
focal adhesions. Apart from this, integrins have the capability of signaling into the cell to
aid in numerous functions like the cell cycle, shape, and cell migration (Giancotti &
Ruoslahti, 1999), and focal adhesion tension. In mammals, 18 alpha subunit and 8 beta
subunits have been recognized and form 24 different integrin molecules. Both of the
subunits contain large N-terminal extracellular domains responsible for binding to ECM
proteins, followed by a short membrane spanning domain which is then linked to a short
intracellular domain. Once integrins have made the ECM attachment, they go through
conformational changes that will increase association with focal adhesion molecules like
talin, vinculin, and Rho GTPase family molecules Rho, Rac, and Cdc42. ECM- or
Ligand-bound conformational changes in integrins have been suggested to induce
outside-in signaling, and if multiple ECM binding sites are provided, integrins will
cluster, promoting kinase activity for downstream signaling (C. Kim, Ye, & Ginsberg,
2011). We have previously reviewed that integrins not only bind to the ECM, but also
bind to a multitude of factors including viruses, bacteria, growth factors, and hormones
(Lafoya et al., 2018). Integrins transmit signals from the extracellular space to the interior
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referred to “outside-in” signaling, but signals can be transduced from inside the cell
called “inside-out” signaling as well, dictating ECM binding affinity. Molecules like
thrombin can manipulate integrin binding affinity through the protein Talin, which is
responsible for binding to the beta subunit tail of integrin heterodimers, essentially
connecting integrins to the actin cytoskeleton (Ginsberg, 2014; Ratnikov, Partridge, &
Ginsberg, 2005).
Integrin Downstream Signaling
It has been established that integrin attachment to the ECM is important for cell
survival and in the absence of cellular attachment, cells can undergo apoptosis (Frisch &
Francis, 1994; Meredith Jr., Fazeli, & Schwartz, 1993). ECM attachment has also been
found to regulate genetic expression involved in multiple cellular functions like survival,
proliferation, motility, and cytoskeleton remodeling. Evidence has uncovered multiple
tyrosine kinases (e.g. Src, FAK) (Kornberg, Earp, Turner, Prockop, & Juliano, 1991;
Rohrschneider, 1980) that localize to focal adhesions and are phosphorylated following
integrin attachment to the ECM. There have also been integrin-associated membrane
proteins that have been identified to couple with integrins and regulate their response
including CD47, growth factor receptors, syndecan heparin sulfate proteoglycan
receptors, and many more (Miranti & Brugge, 2002). Since these connections have been
established, studies have investigated the downstream genetic effects of integrins and the
roles they play in cellular behavior. Recent evidence has also revealed that integrins
influence downstream pathways through extracellular cues like shear stress and matrix
stiffness (J. Chen et al., 2015; D A Chistiakov, Orekhov, & Bobryshev, 2016; Du et al.,
2016; Shih, Tseng, Lai, Lin, & Lee, 2011; Y. Wang et al., 2002).
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Shear Stress
Cardiovascular System
The cardiovascular system is a network of vasculature that provides nutrients and
oxygen via blood to the cells throughout the body. Blood consists of red and white blood
cells, plasma, and platelets and is pumped through the vasculature by contractions from
the heart. The cardiovascular system can be divided into two main groups: arteries and
veins. Arteries function to deliver oxygenated blood (pulmonary artery is an exception)
from the heart to the tissues of the body. Tissues receive oxygen and nutrients from the
blood through “leaky” capillary beds into the interstitial fluid of the tissues. Capillaries
connect the arteries to the veins, where oxygen/nutrient deficient blood (pulmonary vein
is an exception) is carried back to the heart. Blood vessels are essentially made up of
three layers, the tunica intima, media, and adventitia. Tunica intima is the inner most
layer and consists of a monolayer of epithelial cells called the endothelium that line the
interior of vessels and are attached to a substrate of extracellular matrix made up of
mostly structural proteins (e.g. collagen) called the basement membrane. Endothelial
cells (ECs) are responsible for vascular permeability, regulating inflammation, preventing
thrombosis, and controlling the integrity of the vessel (Dimitry A. Chistiakov, Orekhov,
& Bobryshev, 2015). Surrounding the intima is the tunica media which is comprised of
smooth muscle cells and interstitial ECM molecules that are responsible for
vasoconstriction and dilation of the vessel tube. Finally, the external layer, the tunica
adventitia, mainly made up of collagen, provides elasticity and connects the vessels to the
surrounding tissue (figure 1.2).
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Figure 1.2: Blood vessels consist of 3 main layers. The tunica intima is composed of
endothelial cells surrounded by a basement membrane and regulates vessel
permeability and integrity. The tunica media has smooth muscle cells and matrix
proteins and is mainly responsible for contraction/dilation of the vessel, and the
tunica adventitia consists of mostly ECM proteins and associates the vessels with the
surrounding tissue and provides elasticity.
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Hemodynamics
Hemodynamics refer to the physical forces on the endothelium of blood pumping
through the vasculature from the contractions of the heart. Shear stress is a parallel,
hemodynamic force from the flow of blood acting on the endothelium of the vessel walls.
The force from blood flow is considered to be non-Newtonian in the sense that the
vessels are non-uniform and the blood viscosity changes with varying shear stress which
is why it is calculated with considerations of fluid flow, viscosity, and vessel dimensions
(Ballermann, Dardik, Eng, & Liu, 1998). Shear stress is typically measured in dyn/cm^2
where 1 dyn/cm^2 is equal to 0.1 pascals. This force can be conducted via a constant
(laminar) flow seen in normal vasculature conditions or can be a disturbed or oscillatory
flow which can be seen in vascular curvatures, bifurcations, branching and abnormalities
like atherosclerotic plaques and displays a reversal characteristic in the flow. Laminar
flow on ECs induces properties like cell survival, barrier function, antithrombotic
properties, and inhibits immune cell extravasation(D A Chistiakov et al., 2016), whereas
disturbed or oscillatory flow promotes increased permeability of the endothelium,
apoptosis, immune cell adhesion and alters cell morphology, all characteristics of
atherosusceptibility (D A Chistiakov et al., 2016; Zhou, Li, & Chien, 2014).
Mechanotransduction
Upon the implementation of shear stress to ECs, it has been suggested that the
force is first transmitted from the apical surface of the cell to the cytoskeleton. A major
characteristic of EC’s response to laminar shear stress is the morphological alignment of
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the cells parallel to the flow of blood by reorganizing the cytoskeleton and developing
actin stress fibers (Mengistu, Brotzman, Ghadiali, & Lowe-Krentz, 2011; Noria et al.,
2004). Malek and Izumo were able to show that by disrupting microtubules, the
morphological alignment of the cells to blood flow did not occur and actually caused the
cell shape to be a rounded structure, suggesting that microtubules are responsible for
flow-induced alignment (A M Malek & Izumo, 1996). Also, disturbed flow has been
shown to have a similar response to microtubule disruption where ECs fail to align with
the direction of flow and show this rounded shape, causing greater resistance to the flow
force inducing pro-atherogenic characteristics (Heo, Fujiwara, & Abe, 2011; Zhou et al.,
2012). Rho-family GTPases have been widely demonstrated to also control actin fiber
development and cytoskeleton rearrangement through integrin activation following shear
stress (Tzima, 2006; Tzima, Del Pozo, Shattil, Chien, & Schwartz, 2001; Yang, Radel,
Hughes, Kelemen, & Rizzo, 2012; Zhou et al., 2014). Secondly, stress of the cytoskeleton
is intracellularly transmitted to the sites of cell-cell adhesion and cell-ECM attachment (P
F Davies, 1997). Some of the main proposed mechanisms of these sites are tight junctions
(occludins) (DeMaio, Chang, Gardner, Tarbell, & Antonetti, 2001), adherin junctions
(VE-cadherins)(Caolo et al., 2018) , Tyrosine Kinase receptors (VEGFR2)(dela Paz,
Walshe, Leach, Saint-Geniez, & D’Amore, 2012; Masumura, Yamamoto, Shimizu, Obi,
& Ando, 2009), and focal adhesions (integrins)(Tzima et al., 2001) among many others
(Figure 1.3). Finally, downstream signaling occurs as a result. Many molecules are
known to have expression changes or modifications (e.g. phosphorylation) from shear
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stress applications. It has been reported that hundreds of genes respond to shear stress,
upregulated and downregulated, and under laminar flow induce anti-atherogenic
characteristics (Resnick et al., 2003). Downstream markers that are used in research to
identify a change in shear stress on cells include endothelial nitric oxide synthase
(eNOS), kruppel-like factor 2 (KLF2), nuclear factor (erythroid-derived 2) like 2 (NRF2),
reactive oxygen species (ROS), vascular endothelial growth factor (VEGF), and more
recently Notch (D A Chistiakov et al., 2016; X.-L. Wang, Fu, Raghavakaimal, & Lee,
2007; Wragg et al., 2014; Zhou et al., 2014).

Figure 1.3: Mechanotransduction. Illustration showing the proposed method of
mechanotransduction. As shear stress forces are implemented to the apical surface
of cells, the force applies tension to the cytoskeleton where it will then transmit to
the focal adhesions and junctions of the cell.
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Notch and Shear Stress
Notch signaling is regulated under the physical conditions of shear stress caused
by blood flow in vascular endothelial cells (Fang et al., 2018; Jahnsen et al., 2015; Mack
et al., 2017; Tu, Li, & Hu, 2014), and lymph flow in lymphatic endothelial cells (Choi et
al., 2017). In vivo and in vitro studies have both revealed Notch activation under a variety
of shear stress conditions. A study in rats determined Notch activation from wall shear
stress by modeling arteriovenous malformations via connecting the jugular vein to the
carotid artery which revealed Notch1 expression to be significantly increased after one
day of wall shear stress in the abnormal junction, and interestingly Notch4 expression
showed a significant upregulation after 3 weeks post Notch1 increase (Tu et al., 2014).
Another in vivo experiment in transgenic adult mice where an inducible deletion of
Notch1 was created presenting evidence that flow-induced Notch1 controls cell polarity,
cell-cell junction maintenance, and the ability to suppress cell proliferation (Mack et al.,
2017).
To receive a shear stress response in vitro, many methods are utilized from orbital
shakers (H. Kim et al., 2015) to flow-loop perfusion devices (Frangos, Eskin, McIntire, &
Ives, 1985; X.-L. Wang et al., 2007). Physiological arterial shear stress typically ranges
between 10-40 dyn/cm^2 (Resnick et al., 2003) whereas physiological venous shear
stress ranges from approximately 1-6 dyn/cm^2 (Wragg et al., 2014). In the case of
atherosclerotic plaques in the arterial system, the fatty buildups tend to form near
bifurcations, arterial arches, and branching points where disturbance in flow occurs
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causing a variation in the shear stress forces along the vessel walls (Chiu & Chien, 2011).
An interesting dynamic recently demonstrated the variation in rate of flow (dyn/cm^2) in
vitro that is necessary to activate Notch signaling. In recent in vitro studies, Notch1
expression or activation occurred from 1-5 dyn/cm^2 up to 15 dyn/cm^2 (Jahnsen et al.,
2015; White et al., 2015), opening the novel topic to many new questions.
As previously mentioned, upon activation of the Notch receptor, which induces
the cleavage events, the separate cytosolic portion of the protein (NICD) travels to the
nucleus where it engages with the co-transcriptional factors MAML and RBP-J inducing
transcription of particular genes. Among these genes the most widely accepted and used
targets are the mammalian homologs of hairy and enhancer-of-split in drosophila, hes
and hey genes (Fischer & Gessler, 2007; Tosello & Ferrando, 2013). These genes are
common markers for activation of Notch signaling in mammalian cells. Since these genes
do seem to be upregulated during shear stress, this suggests that Notch receptor activation
is being increased under these conditions. This raises the question of whether this
phenomenon is taking place due to increased activation of the receptor itself or is the
upregulation taking place due to increased expression of Notch, thus creating a higher
concentration of receptors at the membrane. One way this can be examined is by
detecting the expression levels of the Notch protein. Not only does the majority of the
recent literature show the expression levels of Notch increase from shear stress (Jahnsen
et al., 2015; Qin et al., 2016; Tu et al., 2014; White et al., 2015), but also expression
levels of Notch ligands show increase (Fang et al., 2018; Jahnsen et al., 2015; Qin et al.,

17

2016; Tu et al., 2014) suggesting higher levels of Notch activation due to an increase in
membrane concentration of the proteins and its ligands. Although, the upregulation in
expression mainly occurs hours after shear stress implementation. Further research could
address this by possibly inhibiting protein translation (e.g. via cycloheximide) and testing
downstream genes to see if upregulation still takes place.
Variations in hemodynamic shear stress is a major contributor to the development
of atherosclerotic plaques. Steady, laminar flow induces anti-atherosclerotic properties in
endothelial cells by promoting certain phenotypes including inhibition of thrombotic
activity, inflammation, proliferation, etc (Gimbrone & Garcia-Cardena, 2013). As
previously mentioned, atherosclerotic plaques tend to form near branch points,
curvatures, and bifurcations where the shear stress forces on the endothelium exhibit a
low non-laminar style, disturbed flow inducing pro-atherosclerotic vascular properties
like endothelial dysfunction and inflammation(Chiu & Chien, 2011; Cunningham &
Gotlieb, 2004; Gimbrone & Garcia-Cardena, 2013; Heo, Fujiwara, & Abe, 2014;
Ravensbergen, Ravensbergen, Hillen, & Hoogstraten, 1998). Canonical Notch1 activity
in the endothelium has been shown to suppress endothelial cell activation, white blood
cell attachment, and pro-atherosclerotic molecule overexpression (Anaïs Briot et al.,
2015; Anais Briot, Bouloumie, & Iruela-Arispe, 2016).
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ECM
Overview
Tissues comprise of cells and ECM. The ECM is a highly variable collection of
secreted structural and non-structural molecules in the intercellular space of tissues to
provide functions like cell adhesion (e.g. focal adhesions, cell-cell attachment),
communication, and differentiation. In mammals, two types of ECM exist and are located
in the interstitial space of tissue that or in the basement membranes separating epithelial
layers from surrounding connective tissues and regulates cell polarity, proliferation, and
migration. The ECM is composed of mainly proteins and glycosaminoglycans (GAGs).
GAGs in the ECM can connect to protein cores to establish a proteoglycan molecule
which serves to keep the ECM hydrated and gel-like. Major proteins of the interstitial
ECM include collagen, elastin, and fibronectin, whereas in the basement membrane the
ECM proteins are mainly collagen and laminin.
ECM Stiffness
When cells adhere to the ECM via focal adhesions, the actin cytoskeleton senses
tension and responds. The stiffness of the ECM is dictated by the concentration of
structural proteins like collagen. It has been shown that cells on stiffer ECM show higher
organization in the cytoskeleton and more stability in the focal adhesion complex
(Discher, Janmey, & Wang, 2005). Young’s elastic modulus is used to measure the
resistance from substrates by the application of force to a specific area and measuring the
change in length (Wells, 2008). This is recorded in Pascal units (newtons/m2). Stiffness in
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tissues varies greatly throughout the body where brain tissue stiffness measures in the
hundreds of pascals (Miller, Chinzei, Orssengo, & Bednarz, 2000) compared to muscle
tissue which measures from 5-12 kPa (Cox & Erler, 2011). Cells respond and regulate
their behavior depending on the stiffness of their substrate matrix including proliferation
(LaValley et al., 2017), migration (Asano et al., 2017), and differentiation (Shih et al.,
2011). Fibrosis is a hallmark pathology that is associated with matrix stiffness and results
from excessive accumulation of ECM components secreted typically by fibroblasts and
eventually can result in organ failure. The onset of this condition is commonly a result of
organ or tissue injury and mimics scarring. There are also molecular pathways involved
in fibrosis, most notably transforming growth factor-beta (TGF-) which induces Smad
signaling pathways causing activation of fibroblasts, excessive ECM production, and
inhibition of degradation. In recent years, Notch has been shown to be associated with
fibrosis. For instance, during liver and kidney fibrosis in rodents, Notch was shown to be
significantly upregulated (Bielesz et al., 2010; Y. Chen et al., 2012).
Experimentally, polyacrylamide hydrogels with variable stiffnesses can be used to
test cell’s response in vitro. This can be done by mixing acrylamide and biz-acrylamide,
with stiffness depending on the ratio of each, and allowing the solution to polymerize on
glass surfaces. Following this, a cross-linker must be used (e.g. L-DOPA, Sulfo-sanpah)
to link the acrylamide to an ECM protein where then cells may be cultured on the surface
(Tse & Engler, 2010; Wouters, Ploeger, van Putten, & Bank, 2016a, 2016b) (figure 1.4).
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Figure 1.4: Polyacrylamide hydrogel. Illustration of experimental hydrogels. A
glass coverslip is used to attach polyacrylamide hydrogel. The hydrogel is then
crosslinked to an ECM protein using crosslinkers like L-DOPA or Sulfo-sanpah.
The cells are then cultured on the surface attaching to the ECM protein with focal
adhesions.
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CHAPTER TWO: INITIAL SHEAR STRESS-INDUCED NOTCH SIGNALING IS
REGULATED THROUGH AND INTEGRIN PATHWAY
Abstract
The hemodynamic forces that manipulate cellular signaling in endothelial cells
play an important role in the differentiation and the overall behavior of these cells. Notch
activation is an important factor in regulating endothelial cell behavior including antiatherosclerotic properties. Previous studies have revealed that Notch signaling is
upregulated from the forces of blood flow acting on the cell, yet the intermediate
mechanisms remain unknown. We demonstrate that Notch signaling is indeed
upregulated following ~12 dyn/cm^2 of shear stress and that by inhibiting integrin
activation the shear stress upregulation of Notch signaling is abrogated, specifically
through a Hey1 downstream pathway. Also, we have identified that by inhibiting
integrin-activation downstream molecules, Src and eNOS, the shear-stress-induced Notch
activation is again significantly reduced, suggesting these molecules are required for this
event. From these findings, we can deduce that Notch activation is regulated by the micro
environmental pressures of shear stress through an integrin pathway.
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Introduction
Hemodynamic forces play an important role in the vascular system by regulating
the behavior of endothelial cells and vascular smooth muscle cells. A specific example of
these forces called shear stress is implemented to the apical surface of endothelial cells by
the flow of blood. Measurements in the vasculature show that in the arterial system,
average shear stress can measure between 10 - 40 dyn/cm^2 and in the venous system
about 1- 6 dyn/cm^2 (Adel M Malek & Alper, 1999). The impact of force on these cells
has been shown to be involved in numerous cellular responses like morphology,
proliferation, and signaling events(D A Chistiakov et al., 2016; Resnick et al., 2003;
Zhou et al., 2014). Many different molecules of the cell act as mechanosensors that
transduce a signal to the cell which will then respond accordingly. These molecules
include junctional proteins (e.g. occludins)(DeMaio et al., 2001; Gulino-Debrac, 2013),
growth factors (e.g. VEGF)(dela Paz et al., 2012), and focal adhesions (e.g.
integrins)(Ross et al., 2013). Integrins consist of two subunits, alpha and beta, that
heterodimerize to become a functional unit that attaches to the extracellular matrix in
endothelial cells. This connection to the ECM allows for focal adhesion, ultimately
connecting the exterior of the cell to the interior cytoskeleton. Many studies have linked
integrins and shear stress, showing a tendency for the proteins to regulate
mechanotransductional signals from the blood-flow force (J. Chen et al., 2015; K. Chen
et al., 1999a; Y. Wang et al., 2002; Yang & Rizzo, 2013).
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Notch proteins are transmembrane, heterodimeric receptors that respond to
Delta/Serrate/LAG-2 (DSL) ligands on adjacent cells. When ligand binding occurs, the
adjacent cell proceeds to endocytose the ligand-receptor complex inducing ADAM
metalloproteinase to cleave the extracellular domain from the receptor. Subsequently,
gamma secretase then cleaves the intracellular domain (NICD) from the remaining
transmembrane portion. The NICD then travels into the nucleus where it behaves as a cotranscription factor by binding and inhibiting RBPJ (CSL), a negative transcriptional
regulator, causing expression of downstream genes, namely the Hairy/Enhancer of Split
(Hes, Hey) family (Fischer & Gessler, 2003, 2007). Recent publications have recognized
that under the influence of shear stress, Notch signaling is upregulated and acts as a
mechanosensor for the arterial endothelium inhibiting pro-atherosclerotic events (Fang et
al., 2018; Jahnsen et al., 2015; Mack et al., 2017; X.-L. Wang et al., 2007). Contrary to
this, it has been shown that shear stress downregulates Notch signaling in the lymphatic
endothelium (Choi et al., 2017). A reduction in Notch1 has also been implicated in
endothelial activation which results in increased leukocyte attachment to the endothelium
and increased expression of pro-atherosclerotic molecules (Anaïs Briot et al., 2015;
Anais Briot et al., 2016). Although Notch activation via shear stress has been
established, little is known about the actual mechanics regulating these phenomena. Our
data aims to answer our hypothesis that integrins regulate Notch activation from shear
stress and that the downstream pathway to this event involves Src kinase and endothelial
nitric oxide synthase (eNOS).
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Results:
Notch Signaling is induced by Shear Stress.
Endothelial Notch signaling is important for cell alignment, endothelium repair,
cellular growth arrest, and maintaining a deactivated endothelial state (Anais Briot et al.,
2016; Z. J. Liu et al., 2012; Theodoris et al., 2015; Venkatesh et al., 2011). The
endothelium relies on a steady laminar flow to maintain these anti-atherosclerotic
properties (Peter F Davies, 2009; Gimbrone & Garcia-Cardena, 2013). Previous studies
reported that Notch signaling was activated when shear stress forces were applied in vitro
and in vivo (Fang et al., 2018; Mack et al., 2017; X.-L. Wang et al., 2007). Notch
signaling has also been shown to be reduced when exposed to circulating lipids.
Additionally, when the lipids reduced Notch signaling, endothelial activation occurred
increasing leukocyte binding and upregulation of pro-atherosclerotic molecules (Anaïs
Briot et al., 2015). To confirm Notch signaling is activated via shear stress, orbital shear
stress was applied to confluent HMEC1s at ~12 dyne/cm^2 for 15 minute increments up
to 90 minutes, which were then compared to a static control. To verify that Notch
signaling was being upregulated under shear stress at the actual receptor, a Western blot
analysis was used with an antibody targeting the cleaved intracellular domain (N1ICD) as
shown in figure 2.1a. The results revealed that the NICD was upregulated after 15
minutes of shear stress and had a peak expression at 45 minutes which then showed
decreasing activity as it approached 90 minutes. To understand if Notch activation
following shear stress is a mechanical response to the force itself or if the response is a
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result of an increase in basal concentrations of Notch at the membrane, we tested the
quantity of full length Notch1 protein and found no change over the time period tested
(figure 2.1a). Previous studies have shown that Notch1 expression does increase from
shear stress, but typically doesn’t show a significant increase until ~4 hours (Mack et al.,
2017; Masumura et al., 2009). Since activated Notch signaling causes a cleavage event of
the receptor, the latent shear stress response of the expression of the full-length receptor
might be to replenish basal levels at the membrane, and not necessarily to increase Notch
activation.
Activation of the Notch receptor triggers the NICD to behave as a co-transcription
factor and induces downstream genetic expression. Since the NICD showed peak levels
after 45 minutes of shear stress, we determined that 90 minutes would be appropriate
amount of time for the downstream genetic expression analysis. qPCR revealed that
Notch downstream genes Hey1, Hey2, and Hes1 were significantly upregulated from the
shear stress forces compared to a static control after 90 minutes of orbital shear stress,
with Hey1 and Hes1 showing the most increase. Krupple-Like Factor 2 (Klf2), a known
gene that is upregulated from shear stress, was used to verify that the cells were
responding to shear stress (figure 2.1b). Surprisingly, Hes1 seems to have a stronger
response to shear stress than does Klf2 under these circumstances. To verify the Hes
family genetic expressions were induced by Notch cleavage, we used a transgenic cell
line that contained a doxycycline inducible promoter that was used to express a truncated
version of mouse Notch1 that excluded the extracellular domain, therefore only
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producing an intracellular domain. After applying doxycycline, Hey1 and Hes1 were
upregulated from the vehicle control, confirming that these genes are induced by Notch
signaling (figure 2.1c). Through cleavage of the Notch receptor itself at the membrane
and Notch downstream gene expression, we have confirmed that Notch activation and
signaling is upregulated under the hemodynamic force of shear stress.
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Figure 2.1: Notch signaling is induced via shear stress. HMEC1s exposed to
~12dyn/cm^2 of orbital shear stress. A) Notch intracellular domain (N1ICD) and
full length Notch1 whole cell lysates detected by Western blot and normalized to
Vinculin control. b) Downstream Notch genes Hey1, Hes1, and Hey2 expression
levels detected by qPCR, Klf2 used as a positive shear stress control. Values are
mean +/- SEM; * = p < 0.05, ** = p < 0.01. c) Downstream Notch genes Hey1 and
Hes1 expression levels detected by qPCR following treatment with Doxycycline in
N1ICD transgenic HMEC1s to overexpress Notch signaling.
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Notch Activation from Shear Stress Is Regulated by Integrins.
Evidence has recently shown that extracellular matrix molecules can regulate
Notch signaling in endothelial cells through an Arginine-Glycine-Aspartate (RGD)
binding integrin pathway (Albig, Becenti, Roy, & Schiemann, 2008; Deford et al., 2016).
Over half of the recognized integrins have binding sites for this amino acid motif
(Ruoslahti, 1996). To clarify if these RGD-binding integrins play a role in shear-stressinduced Notch signaling, RGD peptides (5 g/ml ) were added to the culture media of
HMEC1s, incubated for 24 hours and exposed to orbital shear stress for 45 and 90
minutes. Interestingly, after being treated with the RGD peptide, Hey1 mRNA expression
levels were reduced compared to the vehicle control following shear stress whereas Hes1
mRNA expression showed no response to the peptide after being exposed to shear stress
(figure 2.2a). Since Hey1 mRNA expression is affected by RGD-binding integrins
following shear stress, we decided to inhibit integrins with an alternative method using
Methyl-Beta-Cyclodextrin (MBCD). Methyl-Beta-Cyclodextrin (MBCD) is a chemical
compound that solubilizes cholesterol, therefore, eliminating lipid rafts. As a second
alternative to confirm if integrins are involved in Notch activation following shear stress,
HMEC1s were treated with MBCD (10 mM) for 90 minutes before being exposed to
orbital shear stress for 45 and 90 minutes (figure 2.2b). Upregulation of Hey1 mRNA
expression via shear stress did show a suppression from the treatment of MBCD,
although there was no significant difference between the shear-stress-induced expressions
between the drug and the control, the treatment does abrogate the significance compared
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to the non-flow condition confirming that integrins are involved in the induction of Notch
activation following shear stress. As seen with the RGD binding peptides, flow-induced
Hes1 mRNA remained unchanged from the vehicle control following treatment with
MBCD. Since the Notch downstream genetic expression is affected by the two integrin
inhibiting treatments, activation of the Notch protein at the membrane was tested via
Western blotting (figure 2.2c). The N1ICD quantity did show a suppression of the shear
stress response following treatment with the RGD peptide compared to the vehicle
control and the MBCD treatment provided similar results. Our data strongly suggests that
RGD-binding integrins involved in the activation of Notch signaling following ~12
dyn/cm^2 of shear stress.
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Figure 2.2: Shear Stress-induced Notch is regulated through integrins. HMEC1s
exposed to ~12 dyn/cm^2 of shear stress following integrin inhibition. a) Notch
downstream genes Hey1 and Hes1 mRNA expression detected by qPCR following
treatment with RGD peptides (5 g/ml) and 90 minutes of orbital shear stress. Klf2
used as a positive shear stress control. b) Notch downstream genes Hey1 and Hes1
mRNA expression detected by qPCR following treatment with MBCD (10 mM) and
90 minutes of orbital shear stress. Klf2 used as a positive shear stress control. Values
are mean +/- SEM; * = p < 0.05, ** = p < 0.01. c) N1ICD fragment whole cell lysate
detected via western blot and folded to Vinculin following treatment with RGD
peptide and MBCD and exposed to orbital shear stress for 45 and 90 minutes.
Notch Activation from Shear Stress Is Regulated Via Integrin Downstream Pathways Src
and Enos
Because Hey1 expression via Notch signaling is regulated by RGD-binding
integrins under shear stress forces, we investigated common downstream pathways of
integrin activation. Src kinase is a tyrosine kinase that is involved in numerous pathways
aiding in functions like cell survival, proliferation, and angiogenesis (Pan et al., 2014;
Roskoski, 2015), and studies have shown that Src’s phosphorylating activity can be
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generated through integrin activation (Arias-Salgado et al., 2003; Xiao, Xi, Chen, Chen,
& Meng, 2013). Studies have also shown that Src phosphorylation can be induced via
shear stress integrin activation (Y. Liu, 2002; Tahimic et al., 2016). To determine if Src
kinase is involved in Notch signaling from shear stress, HMEC1s were treated with the
Src inhibitor AZM for a five-hour incubation and then were exposed to orbital shear
stress. mRNA Expression levels of Notch downstream genes, Hey1 and Hes1, were
assessed following treatment with AZM and shear stress (figure 2.3a). From these
experiments, we found that after cells were treated with AZM, a reduction in the shear
stress response occurred. As with the RGD and MBCD data, Hey1 showed a reduction in
shear stress response following AZM treatment, whereas Hes1 again did not. Due to the
high variance of shear stress response, significance was not achieved between the two
variables of Hey1 when compared to the static control, but when the 90 minute AZM
flow response was folded to the 90-minute flow response of the vehicle control, the AZM
treatment was significantly reduced from the latter, firmly suggesting that when
inhibition of Src does occur, Notch shear stress response through Hey1 expression is
abrogated.
Another molecule that has been shown to be downstream of integrin activation
and is also a reported shear stress indicator is endothelial nitric oxide synthase (eNOS)
(Hwang et al., 2015; Yang & Rizzo, 2013). Upon activation, eNOS facilitates the
production of nitric oxide through the amino acid L-arginine, leading to relaxation of the
surrounding vascular smooth muscle cells, vasodilation and increased blood flow
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(Förstermann & Sessa, 2012; Moncada, 1997). Src has also been shown to activate eNOS
via tyrosine phosphorylation (Fulton et al., 2005). It has also been reported that Notch
activation and eNOS are associated. One study identified that Notch inhibition reduced
NO production by inhibiting eNOS activity in tumor vasculature (Patenaude et al., 2014),
while another study suggests that Notch signaling is induced by extracellular nitric oxide
in human glioma cells (Charles et al., 2010). Given that integrins, Src, and Notch have
both shown connections to eNOS, and also that eNOS is activated from shear stress
forces, we hypothesized that eNOS plays a catalytic role in shear-stress-activation of
Notch signaling. To probe this question, we treated HMEC1s with diphenyliodonium
chloride (DPI), a flavoprotein inhibitor that has been shown to effectively inhibit eNOS
activation (Nathan, Stuehr, Gonzalez, Kwon, & Gross, 1991; Peng, Zhuang, Chen, Rizzo,
& Chen, 2015; Sundaresan, Giri, & Chatterjee, 2015), for a 5 hour incubation before
applying shear stress. mRNA expression of three tested downstream Notch genes showed
a significant reduction in the flow-induced response following treatment with DPI (figure
2.3b). Although Hey1 expression in this scenario was not significantly different from the
DPI treatment following the shear stress application, the eNOS inhibition did reduce the
expression levels enough to where the shear stress response was no longer statistically
significant. These results suggest that eNOS activation via shear stress in part regulates
Notch signaling under shear stress conditions.
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Figure 2.3: Shear stress-induced Notch activation is regulated by integrin
downstream pathways, Src & eNOS. HMEC1s exposed to ~12 dyn/cm^2 of shear
stress following treatment with AZM and DPI. a) mRNA expression of Hey1 and
Hes1 detected by qPCR when AZM (10 m) is folded to vehicle control following
shear stress. b) mRNA expression of Hey1, Hes1, and Hey2 detected by qPCR when
DPI (100 M) treatment is folded to static control following shear stress. Values are
mean +/- SEM; * = p < 0.05, ** = p < 0.01. c) Western blot analysis of NICD with
AZM, DPI, and vehicle control.
Discussion:
Vascular blood flow contributes heavily to the behavior of endothelial cells and
induces specific signaling events through the hemodynamic force known as shear stress
(Takahashi, Ishida, Traub, Corson, & Berk, 1997; X.-L. Wang et al., 2007; Zhou et al.,
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2014). Recent studies have revealed that the Notch receptor is activated via shear stress
forces (Fang et al., 2018; Mack et al., 2017; MacK & Luisa Iruela-Arispe, 2018; Tu et al.,
2014), but the determination of whether Notch is a mechanosensor itself or if there is an
upstream mechanosensor causing the activation of Notch is still unknown. From our
experiments, we demonstrate that the Notch1 receptor is activated when induced under
shear stress in as little as 15 minutes and between 15 and 90 minutes, the activation
shows a gradient peaking at 45 minutes. The oscillatory effect could suggest that after 45
minutes of activation, the NICD is simply being degraded. A proteomic analysis has
shown that Notch cleavage did happen after 10 minutes of shear stress but failed to show
the variation in early levels of activation (X.-L. Wang et al., 2007), where we have shown
that early in the response of shear stress, NICD cleavage shows an incremental increase
in NICD accumulation. NOTCH1 protein levels prior to cleavage show no change in
quantity during the application of shear stress, suggesting that Notch is activated via
shear stress either mechanically or through another shear stress response mechanism
rather than upregulation of the full length NOTCH1 receptor itself. This is consistent to a
recent publication also showing no change in Notch1 expression levels occurring in the
first 6 hours of shear stress (Fang et al., 2018), whereas other recent publications show
full-length Notch1 upregulation increasing after four hours (Mack et al., 2017; Masumura
et al., 2009). Collectively, these findings suggest a sequential activation of Notch from
shear stress by first cleaving the existing receptors for signaling, then leading to an
upregulation of the full length receptor to possibly replenish the diminished quantity of
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receptors at the membrane. From the shear stress response, we were also able to verify
significant Notch upregulation via the well-characterized downstream Notch-activated
genes, Hey1, Hey2, and Hes1, which is consistent with the majority of the recent
literature (Fang et al., 2018; Mack et al., 2017; Tu et al., 2014; White et al., 2015).
Interestingly, also consistent from recent studies (Fang et al., 2018; Jahnsen et al., 2015),
Hey2 upregulation from shear stress is minimal compared to the activation of other
downstream Notch genes, suggesting that Notch activated transcriptional regulation is
gene-specific.
Since fluid force seems to have no impact on the upregulation of the expression of
the Notch receptor in the first 90 minutes of shear stress, we decided to investigate
possible upstream mechanisms that might be involved in shear-stress-activated Notch
signaling. It has been widely reported that integrins can be activated by shear stress
forces (J. Chen et al., 2015; K. Chen et al., 1999a; Y. Liu, 2002; Y. Wang et al., 2002),
and that apically located integrins may be responsible (Yang et al., 2012; Yang & Rizzo,
2013). A Previous study has also revealed that RGD-binding integrins play a pivotal role
in Notch signaling and that by inhibiting the activity of these integrins, the Notch
signaling pathways were upregulated (Deford et al., 2016). Knowing this, we investigated
a potential role with RGD-binding integrins by applying soluble RGD peptides to the
culture media. From this analysis, we were able to determine that RGD did reduce NICD
activation from shear stress, and that Hey1 but not Hes1 upregulation was significantly
reduced following the shear stress application. These results suggest that NICD
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transcriptional activity in the Hes family genes is specific under Notch receptor activation
via shear stress and that RGD-binding integrins play a role in this specification. This is
different behavior from the reported relationship between Notch and integrins, showing
that when RGD-binding integrins are inhibited, the flow-induced response of Notch is
decreased rather than increased. Although, our Western blot analysis did show slightly
increased basal levels of NICD, confirming the before mentioned publication.
Because the RGD-binding integrins did show a significant impact on the Notch
response to shear stress, and we do know that integrins are linked to
mechanotransductional signaling, we demonstrated that integrins are in-part responsible
for Notch activation via shear stress by eliminating lipid rafts with methyl-betacyclodextrin, another method in reducing integrin activation. After doing this, we saw
similar results to the RGD peptide response, MBCD reduced NICD activation and Hey1
expression following shear stress, with no response from Hes1. Although the Hey1
response following treatment with MBCD was not significantly different from the shear
stress vehicle control, it did eliminate the significant upregulation when comparing it to
the static control, whereas the shear stress vehicle control did show significant
upregulation compared to the static control. MBCD also reduced the response from the
protein receptor itself, analogous with the RGD-peptide response. From these data, we
suggest that integrins play a role in Notch activation and signaling specification from
shear stress.
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Through identification of integrins regulating Notch shear stress responses, we
investigated downstream integrin molecules, Src and eNOS. Data from these experiments
indicated that inhibition of Src kinase reduces the shear stress response in Hey1 but not in
Hes1, consistent with the integrin data previously mentioned. We have also identified that
eNOS may be downstream of Src activation through shear stress from integrins.
Taken together, our data suggests that Notch is activated under shear stress and
that integrins regulate this activation. Our data also suggests that this activation via
integrins follows a downstream pathway involving Src kinase and eNOS (figure 2.4).

Figure 2.4: Shear stress induces Notch activation through Integrin-Src-eNOS
pathway. Illustration representing the suggested regulation of Notch activation
following shear stress via an integrin-Src-eNOS pathway.
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Methods:
Cell Culture:
HMEC1s were cultured in complete MCDB131 media (Sigma-Aldrich, Co.,
M8537-10L) with 10% EquaFetal Bovine Serum (Atlas Biologicals; EquaFetal, EF-0500A). Cells were cultured on 60 x 15 mm culture dishes (Greiner Bio-One; Cellstar, 628160) at 370 C and 5% CO2 in a humidified incubator.
Shear Stress:
To measure mRNA expression and Protein following shear stress, HMEC1s were
cultured in 60 x 15 mm culture dishes (Greiner Bio-One; Cellstar, 628-160) to confluency
in MCDB131 media (Sigma-Aldrich, Co., M8537-10L) with 10% EquaFetal Bovine
Serum (Atlas Biologicals; EquaFetal, EF-0500-A) and were placed on an orbital shaker
(VWR International; VWR Standard Orbital Shaker, Model 1000, 89032-088) which was
situated inside the humidified incubator at 370 C and 5% CO2 consistent with standard
cell culture environment. The cells were shaken at ~180 rpm for the time periods of 45
and 90 minutes, with control plates at 0 minutes. Orbital shear stress was determined by
using the equation a√𝑛𝜌(2𝜋𝑓)3 where a is the radius of rotation of the oribital shaker, 𝑛
is the viscosity of the medium, 𝜌 is the density of the medium, and 𝑓 is the rotations/sec
of the shaker (Dardik et al., 2005). From this equation, we determined the shear stress
force acting on the cells from orbital shaking to be ~12 dyn/cm2. Prior to being exposed
to shear stress, HMEC1s were treated with either an integrin binding RGD peptide (5
g/ml) (GenScript; RGD, RP20297) for a 24 hour incubation, an eNOS inhibitor
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diphenyliodonium chloride (DPI) (100 M) for a 5 hour incubation, a Src inhibitor AZM
(10 M) (Tocris Bioscience; AZM, 475271) for a 5 hour incubation, or Methyl-betacyclodextrin (MBCD) (10mM)(Alfa Aesar; Methyl-beta-cyclodestrin, J66847) for a 90
minute incubation.
mRNA Expression Analysis:
Following the orbital shear stress application to HMEC1s, total mRNA was
collected by lysing the cells with Ribozol (VWR; Ribozol RNA Extraction Reagent,
N580-200ML). mRNA was reverse transcribed to complimentary DNA using High
Capacity cDNA Reverse Transcription Kit (Thermofisher; High Capacity cDNA Reverse
Transcription Kit, 4368814). qRT-PCR analysis was then applied using a qPCR Master
Mix (Biotium; Fast EvaGreen qPCR Master Mix, 31003-1) with oligos specified for
human mRNA. The dependent variable genes were folded to the house keeping gene actin, and the independent variable, shear stress, was folded to the static control.
Western Blot Analysis:
HMEC1s were lysed with 1X SDS following the orbital shear stress application.
The separation of proteins was performed with SDS-PAGE gels ranging from 6-15% and
were then transferred to a nitrocellulose membrane. Primary antibodies were incubated
on the membranes at 4 oC overnight. Primary antibodies include cleaved Notch1 rabbit
monoclonal antibody (Cell Signaling Technology; Cleaved Notch1 (D3B8), 4147S), antiVinculin rabbit polyclonal antibody (Santa Cruz Biotechnology; Vinculin (H-300), sc5573), and anti-Notch1 rabbit polyclonal antibody (Santa Cruz Biotechnology; Notch1
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Antibody (C-20), sc-6014). Secondary antibodies with HRP-conjugates were applied at
room temperature for a period of 45 – 60 minutes. Protein bands were imaged using a
chemoluminescence imager (Bio Rad; Chemidoc Tough Imaging System, 1708370) and
were quantified using ImageJ 1.50i software.
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CHAPTER THREE: MATRIX STIFFNESS REGULATES NOTCH ACTIVATION
Abstract:
Extracellular matrix stiffness has been highly recognized as a determining factor
for cellular behavior and phenotype. Many signaling pathways have been shown to be
regulated through the composition of the ECM. Polyacrylamide gels have been
experimentally used to aid in determining cellular behavior and signaling pathways.
Fibrosis is a condition that effects the stiffness of ECM and Notch receptors have shown
to play a role in fibrosis. Our results now show that when HMEC1s were cultured on
varying degrees of stiffness, Notch signaling was significantly upregulated. This data
suggests that another micro environmental force is regulating Notch signaling.
Introduction:
Cells throughout the body are exposed to many different types of physical
pressures like hemodynamic forces (e.g. shear stress, stretch, and pressure) and
extracellular matrix (ECM) stiffness. Variations in these forces can alter cellular behavior
and morphology (K. Chen et al., 1999b; Peter F Davies, 2009; Du et al., 2016; Wells,
2008). The ECM is composed of a meshwork of mainly fibrous proteins (e.g. collagen),
proteoglycans, and even growth factors that make up interstitial spaces between cells and
the basement membrane in the vasculature. The ECM can vary in stiffness, which is in
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turn, regulated by the concentration of the ECM proteins, namely collagen, produced
mainly by fibroblasts. Stiffness of the ECM can be measured by using Young’s elastic
modulus and is identified in units of pascals. The degree of ECM stiffness throughout the
body is highly diverse ranging from 100-300 Pa (brain) (Georges, Miller, Meaney,
Sawyer, & Janmey, 2006) to ~3 GPa (bone) (Cox & Erler, 2011). Many pathologies are
associated with ECM stiffness, including fibrosis and sclerosis. Fibrosis typically occurs
in organs when an injury has taken place causing inflammatory cells (e.g. macrophages)
to elicit a response from effector cells (e.g. fibroblasts) resulting in an overproduction of
fibrotic proteins into the ECM which can lead to scarring and possible organ failure
(Rockey, Bell, & Hill, 2015). Attachment of cells to the ECM substrate is implemented
through integrin receptors by binding to ECM molecules like collagen. Integrins are
heterodimerizing proteins made up of alpha and beta subunits and when attached to these
ECM molecules form focal adhesions, connecting the extracellular space to the actin
cytoskeleton of cells. Not only are integrins well known for initiating downstream
signaling events, varying degrees of matrix stiffness have also been shown to regulate
cellular behavior through integrin receptors (Du et al., 2016; Shih et al., 2011; You et al.,
2015).
Notch receptors are also heterodimerizing proteins that aid in numerous cellular
functions including proliferation, cell survival, and differentiation. Notch signaling takes
place when DSL Ligands (Delta or Jagged) on adjacent cells bind the Notch receptor and
induce endocytosis, causing the metalloproteinase ADAM to cleave the extracellular
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domain. Following the extracellular domain cleavage, gamma secretase will then cleave
the intracellular domain (NICD) from the transmembrane portion, allowing the NICD to
travel to the nucleus where it will become a co-transcription factor by binding to RBPJ
(CSL). Many downstream genes are activated by Notch signaling, but the most notable
Notch-induced genes are of the Hairy and Enhancer of Split family (Hes, Hey). Notch
signaling has been shown to be over-activated in liver and kidney fibrogenesis (Bielesz et
al., 2010; Y. Chen et al., 2012). Through our experiments, we aim to confirm our
hypothesis that Notch signaling is regulated through integrins via extracellular matrix
stiffness.
Results:
Notch Activation Changes with Varying Degrees of Matrix Stiffness in Endothelial Cells
Notch signaling in the endothelium is important for many functions including
inhibition of proliferation, cellular alignment, and inhibiting endothelial cell (EC)
activation (Anais Briot et al., 2016; Theodoris et al., 2015; Venkatesh et al., 2011). Notch
signaling has been shown to be regulated by hemodynamic forces like shear stress in the
vasculature (Fang et al., 2018; Mack et al., 2017; Tu et al., 2014; X.-L. Wang et al.,
2007) and lymphatic system (Choi et al., 2017) in endothelial cells. Endothelial barrier
function has also been linked to matrix stiffness, where softer substrates have less F-actin
stress fibers than a stiffer matrix substrate in microvascular and macrovascular ECs
(Birukova et al., 2013). To investigate if Notch signaling changed from varying matrices
stiffness in ECs, HMEC1s were plated on slides containing hydrogels with 10, 20, and 40
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kPa of stiffness. Expression levels of downstream Notch genes were analyzed via qPCR
and revealed that Hey1 showed a significant increase at 20 kPa compared to 10 and 40
kPa matrix stiffnesses (figure 3.1a). Hes1 also showed the same trend but were not
statistically significant. To verify this trend a luciferase assay was conducted under the
same kPa variation and revealed that Hes5 also showed a significant increase from 10 to
20 kPa, although significance from 20 to 40 kPa was not achieved (figure 3.1b). From
this data, we can conclude that matrix stiffness regulates Notch activation in endothelial
cells, suggesting Notch is controlled via integrin focal adhesion.

Figure 3.1: Notch downstream genes are regulated through ECM stiffness. a)
Downstream Notch genes Hey1 and Hes1 were analyzed via qPCR following
culturing on polyacrylamide hydrogels with stiffnesses of 10, 20, and 40 kPa. B)
Downstream Notch gene Hes5 was analyzed via luciferase assay after being cultured
on various stiffness of polyacrylamide hydrogels at 10, 20, & 40 kPa. Values are
mean +/- SEM; * = p < .05, ** = p < .01.
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Discussion:
Extracellular matrix stiffness has relevancy in cellular behavior and signaling.
ECM stiffness can vary throughout the body and changes under various conditions like
fibrosis. Upregulation of Notch has been shown in diseases like fibrosis where the ECM
stiffness was increased due to collagen overproduction (Kavian, Servettaz, Weill, &
Batteux, 2012). Since Notch has shown to change from microenvironment physical
stimuli like shear stress, we hypothesized that Notch changes from varying degrees of
stiffness. Through our analysis of mRNA expression levels and luciferase assays of
downstream Notch genes, we have confirmed that Notch signaling significantly changes
when the ECM stiffness changes from 10 to 20 kPa. These results suggest that another
micro environmental force, ECM stiffness, regulates Notch signaling through the
microenvironment.
Methods:
Cell Culture:
HMEC1s were cultured in complete MCDB131 media (Sigma-Aldrich, Co.,
M8537-10L) with 10% EquaFetal Bovine Serum (Atlas Biologicals; EquaFetal, EF-0500A). Cells were cultured on polyacrylamide gels of varying stiffnesses at 370 C and 5%
CO2 in a humidified incubator. Human adult dermal fibroblasts (HDFa) and Human
hepatic stellate cells (LX2) were cultured in complete DMEM media (Corning Cellgro,
50-003-PB) with 10% EquaFetal Bovine Serum (Atlas Biologicals; EquaFetal, EF-0500-
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A). Cells were cultured on polyacrylamide gels with varying stiffnesses at 37 0 C and 5%
CO2 in a humidified incubator.
Polyacrylamide Hydrogels:
Polyacrylamide gels were created in accordance with Young’s modulus following
protocols by Tse et al. (Tse & Engler, 2010) and Wouters et al. (Wouters et al., 2016a). In
brief, gels were created with mixtures of acrylamide and biz-acrylamide and polymerized
on 12mm glass discs or 25 x 75mm glass slides. L-DOPA (2mg/ml) solution was
incubated on gels for 1 hour in the dark for the purpose of crosslinking the acrylamide
mixture and collagen1 (40 g/ml). Collagen1 was incubated on the gels following LDOPA overnight at 37oC with 5% CO2 in a humidified incubator. Gels were then washed
with PBS and sterilized with UV light for a period of 30 minutes before cell incubation.
mRNA Analysis:
After confluency on 25 x 75mm slides, HMEC1s were lysed with Ribozol (VWR;
Ribozol RNA Extraction Reagent, N580-200ML) for total mRNA collection. Total
mRNA was reverse transcribed to complimentary DNA using High Capacity cDNA
Reverse Transcription Kit (Thermofisher; High Capacity cDNA Reverse Transcription
Kit, 4368814). qRT-PCR analysis was then applied using a qPCR Master Mix (Biotium;
Fast EvaGreen qPCR Master Mix, 31003-1) with oligos specified for human mRNA. The
dependent variable genes were folded to the house keeping gene -actin, and the
independent variable, matrix stiffness of 20 kPa and 40 kPa, was folded to the 10 kPa of
stiffness.
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Transfection:
HMEC1s were transfected with Hes5-luciferase construct (Addgene #41724) and
CMV-Beta-Galactosidase construct () using polythylenimine (PEI) transfection agent
(Polysciences, Inc., #23966-1).
Luciferase Assay:
HMEC1s cultured on hydrogels on 12mm discs were transiently transfected with
150 ng of Hes5-luciferase plasmid and 30 ng of CMV-B-Galactase and incubated for 48
hours. The cells were lysed with 100 l of 1x Firefly Luciferase lysis buffer (Biotium, 5X
Firefly Luciferase Lysis Buffer, 99923) and froze at -80o C for 20 minutes. Firefly
luciferase and Beta-Galactosidase levels were recorded using the Promega Glomax
Multidetection System. Luciferase values were folded to B-Galactase values.
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Notch: A multi-functional integrating system of microenvironmental signals.

Bryce LaFoya2, Jordan A. Munroe1, Masum M. Mia1, Michael A. Detweiler1, Jacob J.
Crow2, Travis Wood1, Steven Roth1, Bikram Sharma3, and Allan R. Albig2,1

Abstract:
The Notch signaling cascade is an evolutionarily ancient system that allows cells to interact
with their microenvironmental neighbors through direct cell-cell interactions, thereby
directing a variety of developmental processes. Recent research is discovering that Notch
signaling is also responsive to a broad variety of stimuli beyond cell-cell interactions,
including: ECM composition, crosstalk with other signaling systems, shear stress, hypoxia,
and hyperglycemia. Given this emerging understanding of Notch responsiveness to
microenvironmental conditions, it appears that the classical view of Notch as a mechanism
enabling cell-cell interactions, is only a part of a broader function to integrate
microenvironmental cues. In this review, we summarize and discuss published data
supporting the idea that the full function of Notch signaling is to serve as an integrator of
microenvironmental signals thus allowing cells to sense and respond to a multitude of
conditions around them.

65
The Cellular Microenvironment:
Conditions of the local environment in which a cell resides can vary widely
depending on the species and its anatomical location within the organism. In recent years,
cellular microenvironments have gained wide acceptance as major determinants
influencing cellular physiology, especially as it pertains to the cancer microenvironment
(Liotta and Kohn 2001), the stem cell niche (Morrison and Spradling 2008), the vascular
system (Giordano and Johnson 2001), and wound healing/granulation tissue (Junker,
Caterson et al. 2013). A multitude of components contribute to a cell’s microenvironment.
Extracellular matrices which surround and support cells contribute chemical and physical
properties to the microenvironment. Both the chemical composition and the physical
stiffness of the matrix provide signaling cues that are actively monitored by cells.
Neighboring epithelial cells, endothelial cells, leukocytes, and fibroblasts are all known to
influence nearby cells chemically through cytokine and hormone secretions, and physically
through cell-cell interactions. Other properties of the cellular microenvironment include
concentrations of dissolved gases such as O2 and CO2, blood sugar concentrations,
temperature, shear stress, oxidative stress, the presence/absence of foreign antigens, and
osmolality. Moreover, cellular microenvironments can change rapidly and dramatically in
response to situations such as wounding and subsequent healing, tumor development,
hypoxia, glucose availability, and fibrosis. Due to the potentially dynamic nature of the
cellular

microenvironment,

cellular

responses

to

both

static

and

changing

microenvironments need to be calibrated to properly and rapidly respond to these
situations. Understanding how cells respond to the incredible complexity of the
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microenvironment requires a systems biology approach to integrate the micro
environmental information, a task that is immensely complicated.
Notch:
The Notch signaling mechanism is a highly conserved developmental pathway that
is used during differentiation in numerous tissues in most, if not all, multicellular
organisms. Evolutionary evidence for the emergence of the Notch receptors first appears
in the choanoflagellates, unicellular flagellated free-living eukaryotic cells widely
considered the closest extant protist relative to metazoans (King, Westbrook et al. 2008,
Richter and King 2013). The genome of the choanoflagellate Monosiga brevicollis encodes
three domains that show similarity to metazoan Notch receptors (Figure A.1A). However,
these domains are split amongst three separate transmembrane proteins in the M. brevicollis
genome including one gene that encodes 36 epidermal growth factor (EGF) like domains,
a second gene that encodes two Lin-12-Notch repeats (LNR domains), and a third gene
that encodes six ankyrin repeats (King, Westbrook et al. 2008). Presumably, these three
ancestral partial Notch homologs were responsible for individual functions. This suggests
that modern metazoan Notch receptors, which unify these domains in a single receptor,
might represent an amalgamation of three independent proteins with independent ancestral
functions and may help explain why Notch is capable of integrating a multitude of cellular
microenvironmental signals and conditions as described in this review. Despite the lack of
a bona fide Notch receptor or Notch ligands, M. brevicollis genome does encode several
other components of the Notch system (Gazave, Lapebie et al. 2009) (Figure A.1B).
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Therefore, the origin of Notch domains (if not function) likely predates the rise of the
metazoans. It has been postulated that these proto-Notch receptors might have served an
adhesive function that was independent of Notch signaling activity and is conserved in
modern Notch function (reviewed in (Murata and Hayashi 2016)). It was not until the rise
of sponges however, that bona fide Notch receptors and ligands appeared and exhibited the
developmental roles that are representative of the metazoan Notch mechanism (Richards
and Degnan 2012). Thereafter, Notch receptors, ligands, and other Notch processing and/or
modifying proteins are expressed throughout all metazoans examined to date (Gazave,
Lapebie et al. 2009).
In mammals, the core of the Notch mechanism consists of five Notch ligands
(Jagged1, 2 and Delta like (Dll) 1, 3, 4) present on the “signaling cell”. The Jagged and Dll
1 and 4 ligands directly interact with and activate a transmembrane Notch receptor (four
different isoforms in mammals) present on the “receiving cell” (Kopan and Ilagan 2009,
Kopan 2010) (Figure A.1B). The Dll3 ligand is a decoy receptor that interferes with Notch
activation (Ladi, Nichols et al. 2005). Notch receptors undergo a maturation process
involving three proteolytic cleavage events that ultimately result in Notch activation. The
first cleavage is performed by a furin convertase during translocation through the Golgi
complex on the way to the cell membrane (Logeat, Bessia et al. 1998). The resulting two
Notch fragments remain non-covalently associated at the membrane where canonical
Notch activation is initiated by interaction between Notch receptors and ligands. Canonical
Notch activation at the membrane is commonly thought to be dependent on a physical
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tugging mechanism of ~ 4-12 pN (Gordon, Zimmerman et al. 2015, Chowdhury, Li et al.
2016) that is initiated by Notch ligand endocytosis in the signaling cell (Parks, Klueg et al.
2000). This pulling force sets up a second cleavage by an ADAM metalloprotease (secretase) producing the transient NEXT (Notch Extracellular Truncation) fragment (Brou,
Logeat et al. 2000), and a third cleavage by -secretase (Mumm, Schroeter et al. 2000) thus
releasing the intracellular NICD domain of Notch that translocates to the nucleus and
functions as a co-transcription factor in association with the CSL transcription factor and
other co-transcription factors including MAML and p300. In addition to this canonical
mechanism, evidence for several non-canonical Notch activation mechanisms have also
been gaining traction. In particular, Notch activation that is independent of canonical
ligands (Palmer and Deng 2015), NICD cleavage and transcriptional activity (Guruharsha,
Kankel et al. 2012), as well as several non-canonical ligands (D'Souza, Meloty-Kapella et
al. 2010) have all been described in the literature. Finally, in addition to the core receptors
and ligands, a wide variety of cellular and secreted proteins have been characterized that
modify Notch signaling either through direct interaction and/or modification of
extracellular Notch receptor or ligand domains (Kadesch 2004) or via post-translational
modification of intracellular NICD fragments (Fortini 2009). References (Kopan and
Ilagan 2009, Kopan 2010) provide excellent in-depth reviews of the Notch signaling
mechanism.
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Notch as an Integrator of Cellular Microenvironments:
While the traditional view of Notch activation focuses on Notch receptor – ligand
interactions, it is becoming increasingly clear that Notch signaling is also influenced by a
wide array of molecules and events in the cellular microenvironment. In particular,
extracellular matrix (ECM) mediated Notch signaling is emerging as a new paradigm for
controlling Notch signaling. Regulation of Notch by ECM occurs on several levels,
including direct interaction between ECM and Notch receptor/ligands, transcriptional
control of Notch receptors and/or ligands, and via cross-talk with other ECM stimulated
signaling networks, such as integrins. In addition, Notch is engaged in crosstalk with a
number of signaling pathways that are initiated by growth factors and cytokines commonly
present in cellular microenvironments including, TGF-, WNT/-catenin, and VEGF.
Finally, Notch can also be regulated by additional conditions such as shear stress, hypoxia,
and hyperglycemia. These microenvironmental conditions are summarized in Table A.1.
Taking into consideration the wide variety of cellular microenvironmental cues that
regulate Notch signaling output, a new picture of Notch is emerging which depicts Notch
as an integrating system for the cellular microenvironment, which enables cells to respond
appropriately to changing ECM composition, growth factor secretions, oxygen tension,
shear stress, and glucose levels. Importantly, this idea is not inconsistent with the classical
model of Notch receptor activation by Notch ligands on adjacent cells, but rather builds on
this model since cellular neighbors are also an important part of a cell’s microenvironment.
The goal of this review is to summarize what is known about the role Notch signaling plays
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in responding to and integrating changing microenvironmental conditions, and to explore
and develop the idea of Notch as a multi-functional integrating system of
microenvironmental signals.
ECM-Notch Interactions:
Extracellular matrices are a major component of a cell’s microenvironment. In
some instances, ECM can be stable over decades. In other situations, ECM is rapidly turned
over and remodeled. Therefore, cells need to be able to adjust to these stable or changing
conditions. Notch responsiveness to the composition of the ECM has only recently begun
to be characterized. The interactions between ECM and Notch can be summarized as either
direct interactions between ECM and Notch receptors or ligands, indirect (transcriptional)
responses of Notch receptors or ligands to ECM, and indirect (crosstalk) interactions
between Notch and ECM stimulated signaling cascades (Figure A.2). Below, we
summarize and discuss these interactions between ECM and Notch signaling.
Direct ECM-Notch Interactions That Control Notch Signaling
Direct interactions between Notch receptors and several ECM proteins have been
described in the literature. Below, we summarize the current data available for several
ECM proteins including Microfibril Associated Glycoprotein-2 (MAGP-2), Epidermal
Growth Factor–like 7 (EGFL7), Nephroblastoma Overexpressed (NOV, CCN3),
Thrombospondin-2 (TSP-2), syndecans 2/3, collagens type I and IV, the Y-box binding
protein (YB-1), and Galectin-3. An interesting observation is that while all these proteins
have been shown to regulate Notch signaling via direct interactions with Notch receptors
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or ligands, there is not a common thread of increased or decreased activity connecting these
proteins. Thus, the Notch regulatory activities of these molecules most likely do not rely
solely on mechanisms involving a simple steric hindrance model. Moreover, several of
these molecules appear to control Notch via multiple mechanisms, suggesting that ECM
control of Notch may be a highly regulated activity.
MAGP-2 is a component of elastic fibrils that are thought to help recruit
tropoelastin to fibrillin containing microfibrils during the development of elastin networks
(Gibson, Hatzinikolas et al. 1996). Since elastin is critical for Windkessel function and
structural integrity of the aortic wall (Belz 1995), it is not surprising that loss of function
of MAGP-2 is linked to aortic dilation in mice (Combs, Knutsen et al. 2013) and familiar
thoracic aortic aneurisms in humans (Barbier, Gross et al. 2014). MAGP-2 may also serve
other functions in the cardiovascular system since MAGP-2 contains an v3 integrin
binding RGD domain and has been shown to control angiogenesis (Albig, Roy et al. 2007)
and vascular density in ovarian cancers (Mok, Bonome et al. 2009). The link between
MAGP-2 and Notch was first made when MAGP-2 was identified as a Jagged1 interacting
protein by yeast-two hybrid screening (Nehring, Miyamoto et al. 2005) and was shown to
induce Jagged1 shedding from the cell surface (Miyamoto, Lau et al. 2006). Subsequent
analysis determined that MAGP-2 and the related protein MAGP-1 both increased Notch
signaling in COS cells (Miyamoto, Lau et al. 2006). Mechanistically, MAGP-2 mediated
stimulation of Notch signaling was shown to involve direct binding between the MAGP-2
C-terminal domain, and the EGF-like domains of Notch1 and Jagged1 (Miyamoto, Lau et
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al. 2006). In addition, RGDRGE mutation of the MAGP-2 integrin binding domain
converted MAGP-2 from a suppressor to an activator of Notch signaling in endothelial
cells suggesting that MAGP-2 may also regulate Notch via interactions with integrins
(Deford, Brown et al. 2016). This finding may help to explain the cell type dependent
effects of MAGP-2 on Notch signaling previously observed (Albig, Becenti et al. 2008)
and suggests that cell type specific control of Notch may be dependent on several factors
including integrin and Notch ligand expression profiles.
EGFL7 is a secreted protein that is specifically expressed from endothelial cells
during development (Fitch, Campagnolo et al. 2004, Parker, Schmidt et al. 2004). EGFL7
is predominantly found in the vascular microenvironment where it appears to be an
important regulator of elastogenesis (Lelievre, Hinek et al. 2008) and angiogenesis (Nichol,
Shawber et al. 2010, Nikolic, Stankovic et al. 2013). In particular, EGFL7 is important for
the formation and maintenance of vascular lumen structures (Parker, Schmidt et al. 2004,
Charpentier, Tandon et al. 2015) and suppressing angiogenic sprouting (Nichol, Shawber
et al. 2010). The first observations that EGFL7 could control Notch signaling were made
in neural stem cell cultures where it was found that the N-terminal half of EGFL7
specifically interacted with EGF domains in Notch1-4 and inhibited Notch signaling
(Schmidt, Bicker et al. 2009). Subsequent work showed that EGFL7 control of Notch in
endothelial and placental trophoblast cells was important for placenta development and
that decreased EGFL7 expression may be linked to preeclampsia (Lacko, Massimiani et al.
2014, Massimiani, Vecchione et al. 2015). In addition to controlling Notch via direct
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interaction with Notch receptors, recent work showed that RGDRGE mutation of the
EGFL7 integrin-binding domain enhanced Notch signaling in endothelial cells (Deford,
Brown et al. 2016). By regulating Notch via direct interactions with Notch receptors and
via RGD integrin binding, EGFL7 demonstrates similarities with MAGP-2 and suggest
that dual control of Notch by ECM molecules is a common theme.
In addition to MAGP-2 and EGFL7, CCN3 (NOV) has also been implicated in the
regulation of Notch signaling (Sakamoto, Yamaguchi et al. 2002). CCN3 belongs to the
ECM CCN family of proteins (CCN1-6) that share a modular structure including of
conserved cysteine knot C-terminal (CT) domain and are multi-functional regulators of
diverse processes including development, osteogenesis, and angiogenesis (Katsube,
Sakamoto et al. 2009). The Notch regulatory activity of CCN3 appears to be important for
controlling a variety of activities including osteoblast differentiation (Minamizato,
Sakamoto et al. 2007, Katsuki, Sakamoto et al. 2008) and trophoblast senescence
(Wagener, Yang et al. 2013, Kipkeew, Kirsch et al. 2016). Regulation of Notch signaling
may be a general feature of the CCN family since CCN2 (CTGF) suppresses Notch
signaling (Smerdel-Ramoya, Zanotti et al. 2008) and CCN1 (Cyr61) is linked to
suppression of Notch1 during the epithelial to mesenchymal transition (EMT) (Haque, De
et al. 2012). Although, mechanistic details describing how CCN3 manipulates Notch
signaling are lacking, the cysteine rich C-terminal tail of CCN3 binds to Notch1
(Sakamoto, Yamaguchi et al. 2002) and is required for Notch regulation (Katsuki,
Sakamoto et al. 2008). Similar to MAGP-2 and EGFL7, CCN3 also interacts with several

74

integrins (in an RGD independent manner) (Lin, Leu et al. 2003) although it is unknown if
control of Notch by CCN3 involves integrin ligation. Interestingly however, CCN1 is
highly expressed near developing blood vessels where it enhances Notch signaling in an
integrin dependent manner (Chintala, Krupska et al. 2015).
Although MAGP-2, EGFL7, and CCN3 are the best characterized examples of
ECM proteins known to regulate Notch activity via direct Notch receptor and/or ligand
interactions, several other ECM molecules have also been implicated in the Notch pathway
and appear to control Notch via direct interactions with Notch receptors and/or ligands. A
common thread among these molecules is Notch3, which appears to be frequently targeted
by ECM interactions compared to other Notch receptors. For instance, Thrombospondin-2
(TSP-2) and Syndecan-2 specifically interact with Notch3 and promote Notch3 – Jagged1
signaling (Meng, Zhang et al. 2009, Zhao, Liu et al. 2012). Conversely, collagen type I and
IV also bind to Notch3 and Jagged1 but suppress downstream Notch signaling (Zhang,
Meng et al. 2013). An additional example of Notch3 regulation by microenvironment is
YB-1. The multi-functional YB-1 protein has widespread DNA/RNA binding activities
(Kohno, Izumi et al. 2003) and has historically been thought of as a cold shock protein
(Kohno, Izumi et al. 2003). Interestingly however, YB-1 can be secreted from mesangial
and immune cells after cytokine stimulation via a non-classical mechanism that involves
ubiquitin E3 ligase HACE-1 mediated K27 ubiquitination and association with the Tumor
Susceptibility Gene 101 (TSG101) (Frye, Halfter et al. 2009, Palicharla and Maddika
2015). In turn, secreted YB-1 has been found to specifically interact with Notch3 EGF
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repeats and to control Notch3 downstream signaling, but not Notch1 signaling (Rauen,
Raffetseder et al. 2009, Raffetseder, Rauen et al. 2011). More recently, non-secreted YB1 was found to control Notch4 expression in triple negative breast cancer cells suggesting
that YB-1 may control Notch on multiple levels (Reipas, Law et al. 2013). Finally, while
Notch3 appears to be a common target for many ECM molecules, it is not the only target.
For instance, while Syndecan-2 regulates Notch3 – Jagged1 signaling (Zhao, Liu et al.
2012),

Syndecan-3

interacts

with

Notch1

receptor,

regulates

processing

by

ADAM17/TACE, and is required for Notch signaling activity in skeletal muscle progenitor
cells (Pisconti, Cornelison et al. 2010). Finally, the sugar binding protein Galectin-3 has
been reported to directly interact with Notch1 in a sugar-dependent manner and to activate
downstream Notch signaling without affecting expression of Notch1 receptor (Nakajima,
Kho et al. 2014).
Collectively, these examples demonstrate that a diverse array of ECM molecules
can influence Notch utilizing a wide variety of mechanisms. Given that each of these
molecules exhibits tissue and/or temporal specific expression patterns, these examples
serve as a dynamic illustration of how Notch responds to changing ECM
microenvironments. With this understanding, it will be interesting to see how future work
refines our understanding of ECM – Notch interactions.
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Indirect ECM-Notch Interactions that Control Notch Signaling (Transcriptional
Mechanisms)
Each of the examples described thus far involve matricellular control of Notch that
appears to be mediated at least in part by direct protein interactions with Notch receptors
and/or Notch ligands. However, other matricellular proteins control Notch activity in a less
direct manner by influencing the expression of Notch signaling components. For instance,
the SPARC protein (Secreted Protein, Acidic, and Rich in Cysteine) stimulates
differentiation of medulloblastoma cells by suppressing Notch signaling (Bhoopathi,
Chetty et al. 2011). However, instead of direct interaction with Notch receptors or ligands,
SPARC seems to transcriptionally control Notch signaling since SPARC null osteoblasts
express increased Notch1 protein (Kessler and Delany 2007) and SPARC protein
transcriptionally suppresses Notch1 expression (Bhoopathi, Chetty et al. 2011). In
comparison to SPARC, which seems to control Notch via direct manipulation of Notch1
expression, other ECM proteins such as Fibulin-3, basement membrane laminins, and MGP
influence Notch signaling by controlling expression of Notch ligands. Fibulin-3 is a
member of the fibulin family of extracellular matrix glycoproteins that are characterized
by tandem repeats of calcium binding EGF sites and a C-terminus fibulin-type module
(Timpl, Sasaki et al. 2003). Fibulin proteins are commonly misregulated during cancer and
have emerged as important microenvironmental regulators of cancer and tumor
angiogenesis (Albig, Neil et al. 2006). In particular, Fibulin-3 has emerged as a biomarker
for pleural mesothelioma and malignant glioma where Fibulin-3 appears to enhance glioma
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malignancy by stimulating tumor cell motility and invasion (Hu, Thirtamara-Rajamani et
al. 2009). Fibulin-3 also enhances tumor angiogenesis in glioma by increasing endothelial
expression of the Notch ligand Dll-4 and simultaneously stimulating ADAM10/17 activity
and downstream Notch signaling (Nandhu, Hu et al. 2014). An interesting observation
however, is that Dll-4 has been extensively shown to limit branching angiogenesis by
suppressing the endothelial tip cell phenotype (Hu, Lu et al. 2011). As an example of this
idea, basement membrane laminins including Laminin-4 and Laminin-111 promote
Notch activation by increasing Dll-4 expression via interaction with integrins (Estrach,
Cailleteau et al. 2011, Stenzel, Franco et al. 2011). As opposed to Fibulin-3 however, Dll4 induction by these laminins appears to be an important mechanism to maintain
endothelial quiescence by limiting tip cell behaviors. Thus, perhaps simultaneous
regulation of ADAM10/17 and Dll-4 enables Fibulin-3 to behave as an angiogenic
promoter in glioma, but to inhibit angiogenesis in other tumors as previously described
(Albig, Neil et al. 2006). Finally, Matrix Gla Protein (MGP) is a well-known inhibitor of
vascular calcification (Luo, Ducy et al. 1997) that functions by binding to and suppressing
the osteogenic programs initiated by BMP-2 and other BMPs (Zebboudj, Imura et al.
2002). In addition to suppressing vascular calcification, MGP has additional roles in the
vasculature since MGP deficiency in mice leads to increased vascular densities, enhanced
tumor angiogenesis (Sharma and Albig 2013), and the development of arteriovenous
malformations (Yao, Jumabay et al. 2011). Mechanistically, MGP deletion results in
increased Notch signaling via enhanced expression of the Notch ligand Jagged1 (Sharma
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and Albig 2013) and accordingly, deletion of a single Jagged1 or Jagged2 allele in MGP
knockout animals suppresses arteriovenous malformations (Yao, Yao et al. 2013).
Although it is not yet clear how MGP controls Jagged1 expression, it appears that MGP
expression is also controlled by Notch in shear-stressed aortic valve endothelium, (White,
Theodoris et al. 2015) suggesting that Notch and MGP are coordinated by a feedback
regulation.
An important observation is that many of the ECM proteins discussed above not
only control Notch signaling, but have also been implicated in the matricellular control of
angiogenesis. Indeed, MAGP-2, EGFL7, the CCN family of proteins (CCN1, 2, 3),
Thrombospondin-2, Syndecan-2, SPARC, collagens I and IV, Fibulin-3, MGP, and
laminins have all been characterized as angiogenic regulators. Given that Notch has
emerged as a major regulator in the cardiovascular system (discussed below), matricellular
control of Notch activity may be a common mechanism whereby the vascular
microenvironment exerts control over angiogenic activity. Hopefully, future research will
be able to determine the relative contributions of these matrix molecules towards Notch
regulation during angiogenic processes and begin to understand how these multiple signals
integrate to control Notch.
Direct ECM Notch Interactions That Control Notch Signaling (Crosstalk Mechanisms).
Reelin is a secreted glycoprotein that is an important regulator of neuronal cell
migration in the developing brain, (Dulabon, Olson et al. 2000, Yip, Yip et al. 2000) and
provides one last mechanism to demonstrate how ECM molecules may control Notch.
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Deletion of Reelin in mice causes an abnormal “reeling” gait referred to as a Reeler
phenotype (D'Arcangelo, Miao et al. 1995). Reelin has several cell surface receptors
including the VLDLR and ApoER2 lipoprotein receptors on neuronal cells that have been
described by several investigators (Hiesberger, Trommsdorff et al. 1999, Ballif, Arnaud et
al. 2003, Bock and Herz 2003). In addition, Reelin has also been described to interact with
integrins 31 and 51 (Dulabon, Olson et al. 2000, Sekine, Kawauchi et al. 2012).
Downstream from these receptors, Reelin signaling typically propagates through Disabled1 (DAB-1) phosphorylation and downstream PI-3K, AKT, and SRC signaling mechanisms
(Ballif, Arnaud et al. 2003, Bock and Herz 2003, Hashimoto-Torii, Torii et al. 2008,
Keilani and Sugaya 2008, Keilani, Healey et al. 2012, Sekine, Kawauchi et al. 2012). Early
work by Keilani et al (Keilani and Sugaya 2008) and Hashimoto-Torii et al (HashimotoTorii, Torii et al. 2008) suggested that Notch may be important for activities downstream
of Reelin. For example, Reelin induces a radial glial phenotype in human neural progenitor
cells, and this effect is phenocopied by activation of the Notch signaling cascade (Keilani
and Sugaya 2008). Moreover, the Notch NICD domain is sufficient to rescue abnormal
migration in neurons from reeler mice (Hashimoto-Torii, Torii et al. 2008).
Mechanistically, Reelin does not appear to directly interact with, or control the expression
of Notch receptors and/or ligands. Instead, Reelin appears to control Notch via
manipulation of downstream signaling networks. For instance, it has been shown that the
downstream Reelin signaling intermediate, DAB-1, physically associates with NICD
(Keilani and Sugaya 2008), that Notch works through DAB-1 to regulate axon guidance in
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Drosophila (Le Gall, De Mattei et al. 2008), and that DAB-1 phosphorylation and SRC
activity are essential for Notch1 activation by Reelin (Keilani, Healey et al. 2012). Taken
together, these results suggest that Reelin may regulate Notch via a mechanism
independent of Notch expression or Notch processing, but dependent on downstream
DAB-1 and/or SRC kinase activities. Although further research is required to confirm this,
the molecular interaction between Notch and SRC is further explored in the Integrin/Notch
crosstalk section below.
Notch crosstalk with other signaling networks. Integrins, TGF-, WNT, and VEGF:
An important distinction between Notch regulation by Reelin compared to other
molecules mentioned in the previous section is that Reelin does not depend on direct Notch
receptor/ligand interactions nor on transcriptional control of individual Notch signaling
components. Instead, the evidence supports a mechanism whereby Reelin interaction with
its cell surface receptors triggers downstream signaling (DAB-1 and SRC) that then
regulates Notch via undefined mechanisms. Thus, Reelin serves as an example of how
Notch signaling can be influenced by crosstalk with other signaling pathways. Similarly,
crosstalk between Notch and several other signaling mechanisms initiated by molecules
including integrins, TGF-/BMP, VEGF, and WNTs in the cellular microenvironment
(Figure A.3) have been described and are discussed below.
Crosstalk between Notch and Integrins:
The earliest evidence that integrins and Notch coordinate comes from studies which
explored the effect of Notch on integrin activation. For instance, Leong et al. demonstrated
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that Notch4 activation in microvascular endothelium increased 1 integrin affinity for
collagen (Leong, Hu et al. 2002). This was taken one step further by Hodkinson et al., who
demonstrated that activation of the small GTPase R-Ras by Notch1 resulted in increased
1 affinity for collagen (Hodkinson, Elliott et al. 2007). Subsequent work on this topic
began to uncover the reciprocal interaction wherein integrins also exert control over Notch.
Initially, integrin control of Notch was focused on transcriptional regulation of Notch
receptors or ligands. For example, work by Weijers et al. (Weijers, van Wijhe et al. 2010)
described an effect of integrin blocking low molecular weight fibronectin fragments on the
expression of the Notch ligand Dll-4 and subsequent Notch activation in endothelial cells.
Similarly, Estrach et al. (Estrach, Cailleteau et al. 2011) and Stenzel et al. (Stenzel, Franco
et al. 2011) demonstrated that Laminin 111 and Laminin 4 increase Dll-4 expression in
endothelial cells via 21 and 61 integrins, and that disruption of this signaling system
had dramatic complications for normal angiogenesis. While these studies suggested a
functional coordination of ECM, integrins, and Notch they did little to dissect a molecular
mechanism, beyond transcriptional control, through which coordination occurs. A handful
of reports however have suggested that Notch control by integrins is not restricted to
transcriptional regulation, but rather, may also engage Integrin Linked Kinase (ILK) and/or
SRC signaling downstream from activated integrins. For instance, Mo et al. (Mo, Kim et
al. 2007) observed that ILK decreased Notch signaling by stimulating ubiquitination and
rapid degradation of the NICD fragment. Similarly, Suh et al. (Suh and Han 2011) showed
that collagen type I increased ILK signaling and NICD accumulation through interaction
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with 21 integrin. In addition to ILK, the non-receptor tyrosine kinase SRC which is
commonly activated by integrin ligation, may also regulate Notch. As eluded to above,
Reelin has been shown to control Notch in a DAB-1 and SRC dependent manner (Keilani,
Healey et al. 2012). Although a molecular interaction between Notch and SRC was not
explored in this study, the authors did show that SRC inhibitors did not affect expression
of Notch1, suggesting a more direct Reelin-SRC-Notch interaction. In support of this, SRC
was found to be an important regulator of Notch S1 processing by furin and that the kinase
domain of SRC binds to and phosphorylates the ankyrin domain of active NICD (Ma, Shi
et al. 2012). Moreover, a genetic interaction between SRC and Notch has been uncovered
during Drosophila development that is critical for normal eye formation (Ho, Pallavi et al.
2015). Taken as a whole, these publications show that Notch can control integrin adhesion
(i.e. inside out signaling), and that integrins can control Notch (i.e. outside in signaling).
Therefore, these data suggest that integrins and Notch are coordinated into a cellular
signaling network that involves feedback control between Notch and integrins and may
involve ILK and/or SRC signaling.
The implications of integrin/Notch crosstalk are potentially quite numerous. In
particular, one field of research that may be impacted by this crosstalk is the study of
pathological tissue fibrosis. Fibrotic diseases are defined by excessive deposition of fibrotic
ECM molecules, increased tissue stiffness, and can occur in most any tissue although
fibrosis of the liver, lung, kidney, and heart represent the major impacts of fibrosis on
human health. Given the increased ECM present in fibrotic tissues, it is not surprising that
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integrins figure predominantly in the pathology of fibrosis (Patsenker and Stickel 2011,
Pozzi and Zent 2013, Chen, Li et al. 2016). Adding to this, it has become apparent that
Notch is also an important regulator of fibrosis in the lung, liver, kidney, and skin (Kavian,
Servettaz et al. 2012, Hu and Phan 2016). For example, strong expression of Notch was
observed in myofibroblasts, the pathological cells associated with the progression of
fibrosis, in lung specimens from patients with idiopathic interstitial pneumonias and in
bleomycin-induced pulmonary model of fibrosis (Aoyagi-Ikeda, Maeno et al. 2011).
Moreover, in airway subepithelial fibrosis, the Notch pathway stimulated the promoter
activity of collagen type I through a Hes1-dependent mechanism (Hu, Ou-Yang et al.
2014). In the kidney, Bielesz et al. showed that upregulation of Notch pathway components
(Jag1/Notch1/HeyL) regulated the development of tubulointerstitial kidney fibrosis in mice
and humans (Bielesz, Sirin et al. 2010). In the liver, the number of Notch1, Notch3 and
Notch4 positive cells were highly upregulated in CCL4 induced fibrosis (Chen, Zheng et
al. 2012). Moreover, activated hepatic stellate cells (HSC) showed an increased expression
of Notch2, Notch3, Hey2 and HeyL (Zhang, Xu et al. 2015). However, after blocking with
the γ-secretase inhibitor DAPT, activated HSC reversed back to quiescent HSC (Zhang,
Xu et al. 2015) and attenuated hepatic fibrosis (Chen, Zheng et al. 2012). Collectively,
these examples clearly illustrate the importance of Notch signaling during fibrotic
responses. Given the crosstalk between integrins and Notch, it will be interesting to
determine if integrins have a strong impact on Notch mediated fibrosis.
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Notch and TGF-:
The TGF- superfamily encompasses more than 30 ligands including TGF-s,
BMPs, activins/inhibins, and Mullerian Inhibiting Substance (MIS) that specifically
interact with at least seven ALK receptors. Activation of ALK receptors by TGF- or other
ligands stimulates SMADs to translocate to the nucleus where they coordinate
transcriptional responses (reviewed in (Gordon and Blobe 2008)). TGF- and Notch
signaling are both involved in several physiological and patho-physiological processes
including embryonic development, wound healing, cancer, and fibrosis. Several lines of
evidence indicate that TGF- and Notch can engage in crosstalk (reviewed in (Kluppel and
Wrana 2005, Tang, Urs et al. 2010)). The first molecular evidence for this interaction was
revealed in a series of papers showing that Notch is synergistic with both TGF- and BMP
signaling. Specifically, Blokzijl et al. demonstrated that NICD can form a transcription
factor complex with SMAD3, an intracellular transducer of TGF- signaling, in chicken
embryos and in mouse myoblast C2C12 cells (Blokzijl, Dahlqvist et al. 2003). In this study,
it was also observed that TGF- upregulated the expression of Hes-1, a Notch target gene,
and the effect was abolished by using a dominant negative form of CSL (Blokzijl,
Dahlqvist et al. 2003). A similar interaction was observed in mouse regulatory T cells in
which NICD cooperates with activated SMAD3 and accelerates its nuclear translocation
(Asano, Watanabe et al. 2008). The importance of TGF-/Notch crosstalk is illustrated by
several reports showing that Notch activity is required for some TGF- effects such as
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TGF-induced EMT (Zavadil, Cermak et al. 2004) and the well-known pro-fibrotic activity
of TGF- (Kavian, Servettaz et al. 2010, Nyhan, Faherty et al. 2010, Chen, Zheng et al.
2012, Xiao, Zhang et al. 2014). Finally, although the majority of interactions between TGF and Notch appear to be synergistic, this may be an oversimplified view of the TGF/Notch interaction. In support of this, Fu et al (Fu, Chang et al. 2009), found that while
Notch did enhance expression of some TGF- responsive genes including PAI1, CTGF,
and CYR61, other TGF- responsive genes including ID1, and ID2, were decreased by
Notch activity. The authors also found that Notch enhanced expression of SMAD3 while
decreasing expression of SMAD1, 2, and 6, suggesting that differential regulation of RSMADs by Notch may be responsible for positive and negative TGF-/Notch interactions.
From this analysis, it appears that the interaction between TGF- and Notch may be more
complex than currently thought.
TGF- however is not the only member of the TGF- superfamily that engages in
crosstalk with Notch. Early work observed that BMP and Notch signals synergistically
reinforced one another during various developmental processes such as Xenopus tail bud
formation (Beck, Whitman et al. 2001) and tooth morphogenesis (Mustonen, Tummers et
al. 2002). Mechanistically, the BMP/Notch crosstalk involves the formation of a
SMAD/NICD transcription factor complex, much like the TGF-/Notch crosstalk
mechanism. Formation of this complex was observed and found to be important for
endothelial function and neuroepithelial cell differentiation (Mustonen, Tummers et al.
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2002, Itoh, Itoh et al. 2004). Follow up work has now determined that crosstalk between
Notch and BMP is important for a wide variety of cellular responses including osteoblastic
differentiation (Nobta, Tsukazaki et al. 2005, Sharff, Song et al. 2009, Hill, Yuasa et al.
2014) and vascular biology/angiogenesis (Larrivee, Prahst et al. 2012, Moya, Umans et al.
2012). Finally, besides TGF- and BMP, little is known regarding crosstalk between other
TGF- superfamily members and Notch. However, given that the majority of the other
TGF- superfamily members utilize ALK receptors and SMAD signaling intermediates, it
seems likely that future research may uncover new crosstalk mechanisms between
members of the TGF- superfamily and Notch.
Notch and WNT:
Like Notch, the WNT signaling network is evolutionarily ancient and heavily
utilized during development. Consisting of ~19 ligands that can bind to ~10 frizzled
receptors and their co-receptors (LRP5/6), the canonical WNT signaling pathway is
mediated by ligand binding to receptor, stabilization and nuclear translocation of -catenin,
and subsequent association with LEF/TCF transcription factors to activate gene specific
promoters. In the absence of WNT signaling, -catenin is phosphorylated by GSK3 which
triggers -catenin ubiquitination and rapid protein turnover (reviewed in (Komiya and
Habas 2008)). The first evidence suggesting a crosstalk between WNT and Notch signaling
was uncovered in Drosophila where it was shown that Notch and WNT cooperate to
control wing development (Couso and Martinez Arias 1994, Hing, Sun et al. 1994). The
first molecular evidence supporting crosstalk between Notch and WNT was made by Ross
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and Kadesch (Ross and Kadesch 2001), when N1ICD was found to increase transcriptional
activity of the LEF transcription factor independently of the canonical Notch transcription
factor, CSL. Instead, it was found that the NICD/WNT crosstalk was mediated by a
NICD/LEF transcriptional complex that regulated a unique subset of promoters compared
to the -catenin/LEF complex (Ross and Kadesch 2001). Similarly, NICD/-catenin
complexes have been identified and found to be important for suppression of neural
precursor cells (Shimizu, Kagawa et al. 2008) and for inducing an arterial fate in vascular
progenitors (Yamamizu, Matsunaga et al. 2010). Despite these results, this NICD/-catenin
complex does not appear to be required for all instances of Notch/WNT crosstalk. Instead,
Hayward et al. demonstrated that membrane-bound Notch is capable of interacting with,
and deactivating -catenin at the cell membrane in a Notch ligand and cleavage
independent fashion (Hayward, Brennan et al. 2005). Subsequent reports reinforced this
finding by showing that -catenin’s association with uncleaved Notch at the membrane is
also important for -catenin regulation in stem cells (Kwon, Cheng et al. 2011), and
imaginal disc development in Drosophila (Sanders, Munoz-Descalzo et al. 2009). Thus,
Notch signaling can alternatively increase or decrease -catenin function, depending on
the nature of Notch/-catenin interaction. Finally, while these reports show that -catenin
is a shared point of overlap during crosstalk between WNT and Notch, other WNT
signaling intermediates have also been shown to interact with the Notch mechanism. For
instance, GSK3, a serine/threonine kinase that is inactivated by WNT signaling (Komiya
and Habas 2008), directly phosphorylates NICD resulting in decreased NICD stability and
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signaling output (Foltz, Santiago et al. 2002, Espinosa, Ingles-Esteve et al. 2003). In this
way, inhibition of GSK3 by WNT signaling results in a positive interaction between the
WNT and Notch signaling mechanisms. In contrast to this, WNT activation of the
Dishevelled protein triggers an inhibitory interaction between WNT and Notch. It is not
completely clear how this is accomplished however since Dishevelled has been shown to
interact both with NICD itself, and with the NICD transcriptional factor CSL in the
nucleus, where it inhibits NICD/CSL mediated transcription (Axelrod, Matsuno et al. 1996,
Collu, Hidalgo-Sastre et al. 2012).
In summary, the interplay between WNT and Notch is very complex and involves
at least four independent mechanisms. This extensive co-regulation may reflect the fact
that both Notch and WNT are both heavily utilized during development, where WNT and
Notch must cooperate for proper development (Collu, Hidalgo-Sastre et al. 2014). Future
studies will no doubt further dissect and define the relative contributions of these pathways
to crosstalk between Notch and WNT signaling.
Notch and VEGF:
The vascular endothelial growth factor (VEGF) signaling pathway coordinates
vascular development through VEGF ligand binding to cell surface receptor tyrosine
kinases. The core of VEGF signaling consists of six broadly expressed VEGF ligands and
four VEGF receptors that are highly restricted to vascular and lymphatic tissues (reviewed
in (Koch and Claesson-Welsh 2012)). A flurry of publishing activity in recent years now
supports a strong crosstalk between the Notch and VEGF signaling mechanisms in the
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vascular system. The basis for Notch/VEGF crosstalk appears to be rooted in the reciprocal
transcriptional control of Notch ligands by VEGF, and VEGF receptors by Notch. For
instance, early work determined that VEGF was an important regulator of Notch receptors
and ligands (Lawson, Vogel et al. 2002, Liu, Shirakawa et al. 2003). Around the same time,
it was also becoming apparent that Notch activity was an important determinant of VEGF
receptor expression (Taylor, Henderson et al. 2002, Holderfield, Henderson Anderson et
al. 2006, Williams, Li et al. 2006). It was not until later, however, when a more complete
picture of the interaction between Notch and VEGF began to come into focus. The prime
example demonstrating reciprocal regulation between Notch and VEGF occurs during
angiogenesis, wherein Notch/VEGF crosstalk has been implicated in the selection and
differentiation of tip versus stalk cells on growing columns of endothelial cells (reviewed
in (Blanco and Gerhardt 2013)). During tip cell selection, VEGF binding to VEGF
Receptor 2 (VEGFR2) at the quiescent endothelial membrane causes a phenotypic switch
into a motile cell state known as a tip cell, while also inducing the expression of Dll-4
(Hellstrom, Phng et al. 2007, Lobov, Renard et al. 2007, Suchting, Freitas et al. 2007). Dll4 expression in tip cells and subsequent binding to Notch receptors on adjacent endothelial
cells (stalk cells) reduces stalk cell sensitivity to VEGF through the down regulation of
VEGFR2, thereby preventing stalk cells from taking on the tip cell phenotype and
restricting the number of new vascular branches (Hellstrom, Phng et al. 2007, Leslie, ArizaMcNaughton et al. 2007). Dll-4 signaling in tip cells also increases Jagged1 expression in
stalk cells which in a twist of understanding, inhibits Dll-4-Notch signaling in tip cells
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resulting in increased VEGFR2 expression and VEGF sensitivity (Benedito, Roca et al.
2009, Pedrosa, Trindade et al. 2015). In this way, VEGF first elevates Dll-4 expression,
which then represses VEGF sensitivity in adjacent cells, thus demonstrating reciprocal
regulation between Notch and VEGF. Beyond tip/stalk cell differentiation, crosstalk
between Notch and VEGF has also been shown to be an important mechanism controlling
other aspects of cardiovascular biology such as arteriovenous differentiation (Fish and
Wythe 2015), differentiation of vascular progenitors from stem cells (Sahara, Hansson et
al. 2014), heart valve development (van den Akker, Caolo et al. 2012), tumor angiogenesis
(Liu, Fan et al. 2014), as well as neuronal development (Thomas, Baker et al. 2013).
Other Microenvironment Conditions That Control Notch (Shear stress, hypoxia,
and hyperglycemia).
As an integrator of cellular microenvironments, the crosstalk between Notch and
other signaling pathways is fairly well described compared to crosstalk between Notch and
other micro environmental conditions. Nonetheless, compelling evidence has been
emerging in recent years, that stimuli such as shear stress in the cardiovascular system, low
oxygen levels (hypoxia), and even hyperglycemia all have significant impacts on Notch
signaling (Figure A.4). Additionally, Notch has been reported to respond to other micro
environmental conditions including high salt in endothelial precursor cell media (Karcher,
Hoffmann et al. 2015) and temperature flux in Drosophila (Shimizu, Woodcock et al. 2014,
Ishio, Sasamura et al. 2015), however these responses will not be further discussed here.
Below we summarize the data and provide mechanistic information (where possible) for
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interactions between Notch and shear stress, hypoxia, and hyperglycemia.
Notch and Shear Stress:
Notch signaling has in recent years been shown to be an extremely important
regulator in the development and function of vascular systems, and many excellent reviews
have been published on the role of Notch in vascular development and function (Gridley
2010, Benedito and Hellstrom 2013). In addition, Notch has also been tightly linked to
several vascular malfunctions including the development of atherosclerotic lesions
(Rusanescu, Weissleder et al. 2008). Recently however, a previously unrecognized role for
Notch in sensing shear stress in the vascular system has also begun to emerge. Shear stress
in the vascular system is a mechanical force applied to endothelial cells by fluid flow and
normally ranges from 1-5 Pa (10-50 dynes/cm2) in arteries and capillaries, to 0.1-0.5 Pa (15 dynes/cm2) in veins (Cohen, Wang et al. 1995). Shear stress is an important component
of the endothelial cellular microenvironment that strongly influences endothelial cell
biology. Laminar (undisturbed) shear stress provides an athero-protective signal to
endothelium, while non-laminar, disturbed, or oscillatory shear stress provokes the
development of endothelial dysfunction and atherogenesis (Glagov, Zarins et al. 1988).
Several endothelial shear stress sensors have been identified and include a wide range of
transmembrane proteins on both the apical and basolateral endothelial surfaces and the
intracellular kinases and signaling networks that are stimulated by these surface proteins
(Zhou, Li et al. 2014). The first demonstration that Notch can serve as a sensor for shear
stress was provided by Wang et al. who showed that Notch signaling targets were

92

differentially regulated after exposure to shear stress for as little as 10 minutes (Wang, Fu
et al. 2007). Masumura et al. subsequently showed that shear stress activates Notch
signaling and that this signal is critical for embryonic stem cell differentiation to
endothelium (Masumura, Yamamoto et al. 2009). Although protein expression of Notch1
and 4, as well as the Notch ligands Dll-4, Jagged1 and 2 increased after exposure to laminar
flow, increased abundance of the active Notch NICD domain was observed prior to
increased Notch receptor/ligand expression, suggesting that shear stress may regulate
Notch signaling on both transcriptional and post-translational levels (Masumura,
Yamamoto et al. 2009). Mechanotransduction by Notch signaling has since been
demonstrated to be an important player in both vascular development (Jahnsen, Trindade
et al. 2015) and dysfunction (Tu, Li et al. 2014). Interestingly, inhibition of Notch under
atherogenic / low shear stress conditions was shown to inhibit several pro-inflammatory
molecules, suggesting that inappropriate activation of Notch by low shear stress may also
be linked to the early stages of atherogenesis (Qin, Zhang et al. 2016). While these findings
clearly implicate Notch in endothelial shear stress responses, it is not currently understood
how Notch signaling is activated by shear stress. It seems unlikely that activation of Notch
is wholly dependent on transcriptional mechanisms since Notch activation is observed after
as little as 10 minutes of shear stress (Wang, Fu et al. 2007). However, it has also been
shown that inhibition of VEGFR2 signaling during shear stress blocks Notch activation
(Masumura, Yamamoto et al. 2009), suggesting that if Notch receptors are flow sensors,
that they do not act alone during endothelial response to shear stress. Taken together, these
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findings illustrate the important role Notch plays in responding to shear stress in the
endothelial microenvironment. Future work will hopefully further explore the mechanism
by which Notch is activated by shear stress and continue to define the importance of Notch
in endothelial/vascular response to shear stress.
Notch and Hypoxia
Notch signaling responds to oxygen content within the cellular microenvironment,
showing differential activity under normoxic and hypoxic conditions. The first evidence
suggesting that Notch might be involved in hypoxic responses came when researchers
observed that Dll4 expression was increased in hypoxic tissues (Mailhos, Modlich et al.
2001). Soon after, Notch signaling was observed to be increased in hypoxic neuroblastoma
cells (Jogi, Ora et al. 2002). Further investigation has discovered a physical interaction
between NICD and HIF-1α (Hypoxia Inducible Factor α), which was promoted by hypoxia
and lead to inhibition of cellular differentiation (Gustafsson, Zheng et al. 2005). A similar
observation was also made in Drosophila when it was observed that Sima (the Drosophila
HIF1- homolog) could also activate Notch receptor in a ligand-independent manner
(Mukherjee, Kim et al. 2011). HIF-1α binds to NICD, stabilizes it, and enhances the
transcriptional activation of Notch downstream genes through an association with NICD
transcriptional complexes (Gustafsson, Zheng et al. 2005). Subsequently, it was shown that
hypoxia induced HIF-1α also serves to activate γ-secretase through a direct interaction,
promoting invasiveness and metastasis in murine breast cancer cells (Villa, Chiu et al.
2014). Furthermore, HIF-1α can upregulate expression of the Notch ligand Dll-4 in
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endothelial progenitor cells (Diez, Fischer et al. 2007), and lymphatic vessels (Min, Lee et
al. 2016). Finally, further sophistication of this mechanism is achieved through FIH (Factor
Inhibiting HIF-1α), an asparagine hydroxylase (Scholz, Rodriguez et al. 2016), which
works to inhibit HIF-1α activity in an O2 dependent mechanism (Mahon, Hirota et al.
2001). FIH also negatively regulates Notch target gene transcription (Gustafsson, Zheng et
al. 2005), likely through its hydroxylation and destabilization of NICD under normoxic
conditions (Zheng, Linke et al. 2008). Collectively, the multiple mechanisms by which
hypoxia controls Notch including HIF-1α association with Notch transcriptional
complexes, γ-secretase induction, promotion of ligand expression, and FIH activity provide
at least four independent mechanisms by which Notch cooperates in hypoxic responses.
Notch and Hyperglycemia:
Recent work has begun to dissect a molecular mechanism by which Notch signaling
may respond to increased or decreased blood sugar and possibly play a role in diabetes and
the vascular and renal complications associated with diabetes. For example, Notch
signaling in hepatocytes is increased in response to high sugar concentrations (Valenti,
Mendoza et al. 2013) and hyperglycemia induced Jagged1 expression in endothelium was
proposed to be an important mediator of diabetic vasculopathy (Yoon, Choi et al. 2014).
Moreover, several investigators have shown that hyperglycemia elevates Notch receptor
expression/signaling in cultured podocytes (Gao, Yao et al. 2013, Wang, Yao et al. 2014,
Liu, Zhang et al. 2015), and elevated Notch signaling has been linked to a loss of
glomerular filtration due to a negative impact on podocyte function (Niranjan, Bielesz et
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al. 2008, Waters, Wu et al. 2008). Thus, hyperglycemic stimulation of Notch may be
extremely important for understanding the pathology of diabetic nephropathy, especially
since podocyte damage in diabetic kidneys has been proposed to be an early triggering
event leading to other downstream renal complications (Lin and Susztak 2016). In support
of this, treatment of Streptozotocin induced diabetic mice with the angiotensin inhibitor
Valsartan, simultaneously decreased renal damage and Notch activation (Gao, Yao et al.
2016). Mechanistically, the link between hyperglycemia and Notch has been elusive,
however it is known that hyperglycemia (as well as hypoglycemia) induce VEGF secretion
and signaling (Natarajan, Bai et al. 1997, Kemeny, Figueroa et al. 2013). Given the
reciprocal transcriptional regulation between VEGF and Notch (as described above), it
seems likely that VEGF and Notch may pathologically synergize in hyperglycemic
conditions. In support of this, a recent report by Chiu et al. found that hyperglycemia
increased endothelial secretion of heparinase leading to increased VEGF release from
neighboring myocytes thus enhancing endothelial Notch activity (Chiu, Wan et al. 2016).
Interestingly, anti-VEGF therapies have shown some success in reducing diabetic renal
dysfunction (de Vriese, Tilton et al. 2001, Flyvbjerg, Dagnaes-Hansen et al. 2002),
although it is unknown whether these anti-VEGF approaches also reciprocally decrease
Notch signaling. It has also been shown that inhibition of Notch reduced the elevated
VEGF secretions in podocytes cultured under hyperglycemic conditions, as well as diabetic
nephropathy in diabetic rats (Lin, Wang et al. 2010). Finally, there may be other Notch
regulatory mechanisms beyond VEGF that are operant during hyperglycemic conditions.
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For example, hyperglycemia induced Notch activity seems to be also be linked to decreased
CARM1 methyltransferase activity (Kim, Lim et al. 2014), a recently discovered negative
regulator of Notch signaling (Hein, Mittler et al. 2015). Hopefully future research will be
able to more clearly define the molecular mechanism by which hyperglycemia controls
Notch in order to more fully understand the downstream implications of Notch signaling
in diabetes.
Conclusions:
Through the examples presented in this review, it is clear that Notch signaling is
capable of responding to a range of changing microenvironmental conditions that go far
beyond the basic model of receptor-ligand interaction for Notch activation. Instead,
evidence is building that the basic model of Notch activation is manipulated by a variety
of microenvironmental cues and that the basic cell-cell interaction model of Notch
activation represents only a part of the broader function of Notch to sense and respond to
a wide variety of microenvironmental conditions. Despite these findings, many of the
results discussed here have been gained from simplified models of cellular
microenvironment. In order to build a more complete understanding of how Notch serves
its role as an integrator of cellular microenvironments, future studies will need to examine
how Notch responds to these conditions in more complex in vivo models, an undoubtedly
complex task. In addition, fleshing out the molecular underpinnings of how Notch responds
to microenvironmental conditions is an important goal that should provide opportunities
for pharmacological intervention in the many diseases and processes that are characterized
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by altered microenvironments. Lastly, efforts to therapeutically manipulate Notch are
ongoing for the treatment of a wide variety of diseases (reviewed in (Andersson and
Lendahl 2014)). Therefore, an understanding of the full spectrum of activities that Notch
serves in the microenvironment is an important consideration in developmental biology
and various Notch targeting strategies.
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Table A.1:
Basic and proposed mechanisms by which Notch responds to various
microenvironmental signals.
ECM – Notch (Direct interaction mechanism)
Protein Name

Basic/Proposed Mechanism(s):
-Decrease Notch in RGD/integrin dependent manner
-Interacts with EGF-like domains of Notch1 + Jagged1, activates cleavage

MAGP-2

-RGD/integrin dependent Notch activation
-Interaction with Notch EGF domains and resultant Notch inhibition
EGFL7

-Binds Notch1 receptor and stimulates Notch receptor activation
CCN3

-Binds Notch3, activates Notch3/Jagged signaling
TSP-2
-Syndecan-2 binds Notch3, activates Notch3/Jagged signaling
-Syndecan-3 interacts with Notch1
Syndecans
-Interacts with Notch3, blocks Jagged1 – Notch3 signaling
Col IV
-Interacts with Notch3, blocks Jagged1 – Notch3 signaling
Col I
-Binds Notch3 EGF-like repeats, blocks Notch3 but not Notch1 signaling
YB-1

-Binds Notch1 glycosylations, increases NICD processing
Galectin-3

Ref.
(Deford,
Brown et al.
2016)
(Nehring,
Miyamoto et
al. 2005,
Miyamoto,
Lau et al.
2006)
(Deford,
Brown et al.
2016)
(Schmidt,
Bicker et al.
2009)
(Sakamoto,
Yamaguchi
et al. 2002,
Katsuki,
Sakamoto et
al. 2008)
(Meng,
Zhang et al.
2009)
(Zhao, Liu et
al. 2012)
(Pisconti,
Cornelison et
al. 2010)
(Zhang,
Meng et al.
2013)
(Zhang,
Meng et al.
2013)
(Rauen,
Raffetseder
et al. 2009,
Raffetseder,
Rauen et al.
2011)
(Nakajima,
Kho et al.
2014)
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ECM – Notch (Indirect transcriptional mechanism)
Protein Name
Basic/Proposed Mechanism:

SPARC

Fibulin-3
Laminin 4

-Suppresses Notch by blocking Notch1 transcription

-Enhances Dll-4 expression, ADAM10/17 activity, and Notch signaling
-Increases Dll-4 expression, stimulates Notch

-Increases Dll-4 expression, stimulates Notch
Laminin-111

MGP

-Decreases Jagged1 expression, suppresses Notch

ECM – Notch (Indirect cross-talk mechanism)
Protein Name
Basic/Proposed Mechanism:
-Stimulates DAB-1 and SRC signaling. Increases Notch activity

Reelin

Cross-talk with other signaling pathways
Pathway:
Basic/Proposed Mechanism:
-RGD/RGE control of Notch activity. Possible SRC or ILK involvement
-Notch4 / R-Ras mediate increase in 1 integrin affinity

Integrin

TGF-/BMP

WNT

-Transcriptional complex between NICD and SMAD3

-Transcriptional complex between NICD and -catenin
--Catenin interaction with uncleaved Notch receptor
-GSK3 mediated phosphorylation of NICD, Notch inhibition
-Dishevelled interaction with CSL, Notch inhibition

Ref.
(Kessler and
Delany 2007,
Bhoopathi,
Chetty et al.
2011)
(Nandhu, Hu
et al. 2014)
(Stenzel,
Franco et al.
2011)
(Estrach,
Cailleteau et
al. 2011)
(Sharma and
Albig 2013,
Yao, Yao et
al. 2013)

Ref.
(HashimotoTorii, Torii et
al. 2008,
Keilani and
Sugaya
2008,
Keilani,
Healey et al.
2012)

Ref.
(Mo, Kim et
al. 2007, Ma,
Shi et al.
2012,
Deford,
Brown et al.
2016)
(Leong, Hu
et al. 2002,
Hodkinson,
Elliott et al.
2007)
(Mustonen,
Tummers et
al. 2002,
Blokzijl,
Dahlqvist et
al. 2003,
Itoh, Itoh et
al. 2004,
Asano,
Watanabe et
al. 2008)
(Ross and
Kadesch
2001,
Shimizu,
Kagawa et

100

-Suppression of VEGFR2 receptors by Dll-4
-VEGF signaling increases Notch1 and Dll-4 expression

VEGF

Other microenvironmental conditions
Condition:
Basic Mechanism:
-Rapid NICD cleavage, transcriptional control of receptor/ligands, possible
involvement of VEGFR2
Shear Stress

Hypoxia

-Transcriptional complex between NICD and Hif1
-Activation of -secretase
-Increase of Dll-4 expression by Hif1
-FIH mediated hydroxylation and destabilization of NICD (Normoxia)

al. 2008,
Yamamizu,
Matsunaga
et al. 2010)
(Hayward,
Brennan et
al. 2005,
Sanders,
MunozDescalzo et
al. 2009,
Kwon,
Cheng et al.
2011)
(Foltz,
Santiago et
al. 2002,
Espinosa,
InglesEsteve et al.
2003)
(Axelrod,
Matsuno et
al. 1996,
Collu,
HidalgoSastre et al.
2012)
(Lawson,
Vogel et al.
2002, Liu,
Shirakawa et
al. 2003)
(Taylor,
Henderson
et al. 2002,
Holderfield,
Henderson
Anderson et
al. 2006,
Williams, Li
et al. 2006)

Ref.
(Masumura,
Yamamoto et
al. 2009, Tu,
Li et al.
2014,
Jahnsen,
Trindade et
al. 2015)
(Gustafsso
Zheng et al.
2005)
(Villa, Chiu et
al. 2014)
(Benedito,
Roca et al.
2009, Min,
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-VEGF mediated increase in Notch receptor expression and NICD accumulation.
-Possible involvement of NICD methylation by CARM1
Hyperglycemia

Lee et al.
2016)
(Mahon,
Hirota et al.
2001, Zheng,
Linke et al.
2008)
(Gao, Yao et
al. 2013,
Wang, Yao
et al. 2014,
Liu, Zhang et
al. 2015)
(Kim, Lim et
al. 2014)
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Figure A.1: Canonical Notch signaling and Notch conservation between human and
Monosiga brevicollis. Throughout Figure 1, conservation of Notch proteins or
domains between human and M. brevicollis is indicated by green (positive), yellow
(unknown), or red (negative) shading according to references (King, Westbrook et al.
2008) and (Gazave, Lapebie et al. 2009). (A) Conservation of mammalian Notch
receptor domains in M. brevicollis. Mammalian (human) Notch receptors contain 36
EGF-like repeats and three LNR or NRR (Lin-12 Notch Repeats or Negative
Regulatory Region) repeats in the extracellular domain. The intracellular portion of
human Notch contains seven ankyrin domains and a PEST sequence at the Cterminal. For simplicity, the intracellular RAM (RBPj Association Module) domain,
two NLS (Nuclear Localization sequence) domains, and TAD (Transactivation
Domain) are not shown in this figure. Please refer to references (Kopan and Ilagan
2009, Kopan 2010) for complete details. Three separate proteins (N1, N2, and N3) in
M. brevicollis contain six Ankyrin domains, two LNR domains, and 36 EGF-like
repeats respectively (King, Westbrook et al. 2008). (B) Model of canonical Notch
activation mechanism. Notch receptors are modified in the secretory pathway
(ER/golgi) by Furin cleavage (S1 cleavage) and glycosylation of EGF-like domains by
O-fucosyltransferase (O-fut), Rumi/Poglut1 (Protein O-Glycosyltransferase 1), and
fringe family glycosyltransferases. The Furin cleavage products remain noncovalently associated in the membrane where a pulling force initiated by Notch ligand
endocytosis in sending cells enables further cleavage by -secretase (S2 cleavage,
NEXT fragment) at the LNR domain, and -secretase (S3 cleavage, NICD fragment)
in the membrane of receiving cells. Several regulatory proteins including Numb,
Notchless, and Deltex control Notch availability at the membrane. After -secretase
cleavage, the NICD fragment translocates to the nucleus where it displaces the
transcriptional co-repressor SMRT from CSL/RBP-jk. NICD participates in a
transcriptional complex with CSL, MAML, and p300 to drive transcription of Notch
targets such as Hes and Hey genes. NICD steady-state levels are controlled by nuclear
export, ubiquitination (Ub) by Sel10, and subsequent degradation in the proteasome.
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Figure A.2: Summary of ECM control of Notch signaling. Canonical activation of
Notch receptors by Notch ligands can be manipulated in three ways by cellular
interactions with ECM. 1.) Direct interactions between Notch receptors or ligands
and various ECM molecules can either inhibit or promote activation of Notch
signaling. 2.) Indirect interactions between ECM and Notch are characterized by
ECM mediated increased or decreased expression of Notch ligands on sending cells
or Notch receptors on receiving cells. 3.) Indirect interactions between Notch and
ECM are characterized by ECM mediated activation of signaling pathways that
post-translationally intersect with Notch proteins or signaling intermediates.
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Figure A.3: Crosstalk between Notch and other signaling pathways. Crosstalk
between WNT and Notch occurs on several levels including the formation of a catenin-NICD transcriptional complex, interaction between Notch receptors and catenin at the membrane, phosphorylation of NICD by GSK3, and inhibitory
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interactions between Dishevelled and CSL. The mechanistic interaction between
integrins and Notch is poorly characterized, but existing evidence suggests
ubiquitination and/or phosphorylation of NICD by SRC and ILK kinases. Interaction
between the Notch and VEGF pathways involves the reciprocal transcriptional
regulation of Notch ligands by VEGF, and VEGFR2 by Notch. Notch/TGF-, or
Notch/BMP crosstalk occurs downstream of ALK (TBR1/TBR2 or BMPR1/BMPR2)
receptors and is dependent on R-SMAD and Co-SMAD activation and subsequent
formation of a SMAD/NICD transcriptional complex similar to the -catenin/NICD
complex.

107

Figure A.4: Summary of microenvironmental conditions (shear stress, hypoxia,
and hyperglycemia) that control Notch. Depicted is a cross-sectional view through a
blood vessel showing endothelial cells (EC) and vascular basement membrane. Shear
stress (laminar versus disturbed or non-laminar) controls Notch by largely undefined
mechanisms that may include regulation of Notch receptors and/or ligands. Hypoxia
controls Notch signaling by several mechanisms including the formation of HIF1NICD transcriptional complexes, HIF1 mediated stabilization of NICD, enhanced secretase activity, and FIH mediated NICD destabilization. Hyperglycemia controls
Notch by largely uncharacterized mechanisms that may include increased NICD
stability due to decreased CARM1 expression and/or increased VEGF release from
other cells in the vascular microenvironement.
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